| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 498 | 2024 | 6234 | 22.910 |
Why?
|
| Vitamin D | 79 | 2024 | 3301 | 7.400 |
Why?
|
| Anti-Asthmatic Agents | 49 | 2024 | 574 | 5.130 |
Why?
|
| Respiratory Sounds | 58 | 2024 | 702 | 4.910 |
Why?
|
| Forced Expiratory Volume | 150 | 2024 | 1814 | 4.450 |
Why?
|
| Pharmacogenetics | 33 | 2016 | 675 | 3.820 |
Why?
|
| Polymorphism, Single Nucleotide | 154 | 2024 | 15908 | 3.720 |
Why?
|
| Genome-Wide Association Study | 102 | 2024 | 12661 | 3.520 |
Why?
|
| Bronchodilator Agents | 42 | 2024 | 512 | 3.180 |
Why?
|
| Adrenal Cortex Hormones | 44 | 2024 | 1878 | 3.180 |
Why?
|
| Bronchial Hyperreactivity | 45 | 2017 | 302 | 3.030 |
Why?
|
| Hypersensitivity | 43 | 2023 | 1167 | 2.970 |
Why?
|
| Lung | 110 | 2024 | 9999 | 2.920 |
Why?
|
| Hypersensitivity, Immediate | 33 | 2023 | 347 | 2.910 |
Why?
|
| Pre-Eclampsia | 10 | 2023 | 1230 | 2.740 |
Why?
|
| Vitamin D Deficiency | 25 | 2024 | 1388 | 2.640 |
Why?
|
| Vitamins | 22 | 2024 | 1635 | 2.600 |
Why?
|
| Immunoglobulin E | 63 | 2024 | 1502 | 2.370 |
Why?
|
| Genetic Predisposition to Disease | 111 | 2024 | 17878 | 2.320 |
Why?
|
| Respiratory Function Tests | 63 | 2024 | 1683 | 2.260 |
Why?
|
| Vital Capacity | 67 | 2023 | 971 | 2.160 |
Why?
|
| Bronchi | 36 | 2024 | 846 | 2.140 |
Why?
|
| Lung Diseases, Obstructive | 38 | 2001 | 308 | 2.080 |
Why?
|
| Methacholine Chloride | 38 | 2017 | 220 | 1.860 |
Why?
|
| Polymorphism, Genetic | 41 | 2016 | 4242 | 1.840 |
Why?
|
| Dietary Supplements | 23 | 2024 | 3412 | 1.790 |
Why?
|
| Humans | 1012 | 2024 | 760740 | 1.780 |
Why?
|
| Prenatal Exposure Delayed Effects | 23 | 2023 | 2518 | 1.770 |
Why?
|
| Adrenergic beta-Agonists | 23 | 2014 | 346 | 1.750 |
Why?
|
| Phenotype | 97 | 2024 | 16572 | 1.720 |
Why?
|
| Child | 312 | 2024 | 80089 | 1.700 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 35 | 2024 | 3204 | 1.700 |
Why?
|
| Receptors, Adrenergic, beta-2 | 20 | 2015 | 217 | 1.630 |
Why?
|
| MicroRNAs | 19 | 2024 | 3802 | 1.620 |
Why?
|
| Intracranial Aneurysm | 19 | 2024 | 1285 | 1.620 |
Why?
|
| Allergens | 49 | 2024 | 1429 | 1.610 |
Why?
|
| Smoking | 131 | 2022 | 9054 | 1.590 |
Why?
|
| Pregnancy | 105 | 2024 | 29869 | 1.580 |
Why?
|
| Aneurysm, Ruptured | 14 | 2021 | 464 | 1.580 |
Why?
|
| Genotype | 88 | 2023 | 12977 | 1.570 |
Why?
|
| Female | 591 | 2024 | 392203 | 1.540 |
Why?
|
| Bronchial Provocation Tests | 51 | 2016 | 216 | 1.540 |
Why?
|
| Eczema | 15 | 2022 | 246 | 1.530 |
Why?
|
| Genome, Human | 31 | 2024 | 4421 | 1.500 |
Why?
|
| Cholecalciferol | 7 | 2024 | 553 | 1.480 |
Why?
|
| Male | 624 | 2024 | 360402 | 1.460 |
Why?
|
| Linkage Disequilibrium | 36 | 2021 | 1994 | 1.450 |
Why?
|
| Child, Preschool | 166 | 2024 | 42193 | 1.430 |
Why?
|
| Budesonide | 22 | 2020 | 157 | 1.430 |
Why?
|
| Aging | 75 | 2021 | 8700 | 1.410 |
Why?
|
| Administration, Inhalation | 46 | 2024 | 1156 | 1.370 |
Why?
|
| Gene Expression Profiling | 28 | 2024 | 9417 | 1.370 |
Why?
|
| Skin Tests | 46 | 2016 | 637 | 1.330 |
Why?
|
| Nedocromil | 17 | 2019 | 45 | 1.290 |
Why?
|
| Genetic Variation | 42 | 2024 | 6561 | 1.260 |
Why?
|
| Prenatal Care | 5 | 2020 | 1140 | 1.210 |
Why?
|
| Leukotriene Antagonists | 11 | 2015 | 124 | 1.170 |
Why?
|
| Respiratory Tract Diseases | 16 | 2016 | 750 | 1.160 |
Why?
|
| Sphingolipids | 5 | 2023 | 173 | 1.150 |
Why?
|
| Premature Birth | 6 | 2023 | 1782 | 1.150 |
Why?
|
| Haplotypes | 35 | 2024 | 2713 | 1.100 |
Why?
|
| Anti-Inflammatory Agents | 22 | 2017 | 1810 | 1.090 |
Why?
|
| Fetal Blood | 15 | 2023 | 1347 | 1.080 |
Why?
|
| Epithelial Cells | 10 | 2024 | 3672 | 1.050 |
Why?
|
| Genetic Linkage | 21 | 2008 | 2340 | 1.050 |
Why?
|
| Gene Frequency | 38 | 2024 | 3601 | 1.050 |
Why?
|
| Adult | 381 | 2024 | 220995 | 1.040 |
Why?
|
| Hygiene | 5 | 2015 | 94 | 1.040 |
Why?
|
| Tobacco Smoke Pollution | 25 | 2011 | 820 | 1.000 |
Why?
|
| Spirometry | 43 | 2024 | 928 | 0.990 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 5 | 2009 | 89 | 0.960 |
Why?
|
| Metabolomics | 14 | 2024 | 1656 | 0.950 |
Why?
|
| Genomics | 22 | 2024 | 5822 | 0.950 |
Why?
|
| Gene Regulatory Networks | 16 | 2024 | 1745 | 0.910 |
Why?
|
| Bronchoconstrictor Agents | 14 | 2016 | 77 | 0.910 |
Why?
|
| Lead | 22 | 2021 | 879 | 0.900 |
Why?
|
| Airway Resistance | 6 | 2020 | 406 | 0.880 |
Why?
|
| DNA Methylation | 18 | 2024 | 4392 | 0.880 |
Why?
|
| Respiratory Hypersensitivity | 16 | 2023 | 274 | 0.880 |
Why?
|
| Dermatitis, Atopic | 10 | 2024 | 731 | 0.850 |
Why?
|
| Eosinophils | 21 | 2023 | 953 | 0.830 |
Why?
|
| Software | 18 | 2024 | 4432 | 0.830 |
Why?
|
| Metalloendopeptidases | 5 | 2004 | 393 | 0.830 |
Why?
|
| Environmental Exposure | 35 | 2023 | 4483 | 0.830 |
Why?
|
| Cross-Cultural Comparison | 9 | 2000 | 634 | 0.810 |
Why?
|
| Adolescent | 195 | 2024 | 88247 | 0.810 |
Why?
|
| Food Hypersensitivity | 5 | 2024 | 726 | 0.810 |
Why?
|
| Respiratory System | 5 | 2018 | 563 | 0.800 |
Why?
|
| Interleukin-13 | 9 | 2011 | 392 | 0.790 |
Why?
|
| Developmental Disabilities | 3 | 2020 | 1509 | 0.780 |
Why?
|
| Case-Control Studies | 66 | 2024 | 22153 | 0.780 |
Why?
|
| Computational Biology | 12 | 2020 | 3509 | 0.770 |
Why?
|
| Cohort Studies | 115 | 2024 | 41464 | 0.740 |
Why?
|
| Lung Diseases | 15 | 2018 | 1909 | 0.740 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2022 | 582 | 0.730 |
Why?
|
| Costa Rica | 20 | 2024 | 180 | 0.720 |
Why?
|
| Chromosome Mapping | 21 | 2018 | 4611 | 0.720 |
Why?
|
| Eosinophilia | 11 | 2020 | 559 | 0.720 |
Why?
|
| Gene Expression Regulation | 30 | 2024 | 11874 | 0.720 |
Why?
|
| Middle Aged | 291 | 2024 | 220603 | 0.710 |
Why?
|
| Albuterol | 17 | 2018 | 213 | 0.700 |
Why?
|
| Risk Factors | 141 | 2024 | 74128 | 0.700 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 7 | 2024 | 111 | 0.690 |
Why?
|
| Leukocyte Count | 24 | 2018 | 1597 | 0.690 |
Why?
|
| Alcohol Drinking | 23 | 2022 | 4028 | 0.690 |
Why?
|
| Longitudinal Studies | 97 | 2017 | 14599 | 0.690 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 2011 | 430 | 0.680 |
Why?
|
| Pregnancy Trimester, First | 7 | 2022 | 908 | 0.680 |
Why?
|
| Double-Blind Method | 40 | 2022 | 12333 | 0.670 |
Why?
|
| Genetic Loci | 14 | 2023 | 2624 | 0.670 |
Why?
|
| Genetics, Population | 8 | 2024 | 935 | 0.650 |
Why?
|
| Systems Biology | 4 | 2018 | 481 | 0.650 |
Why?
|
| Respiratory Mechanics | 11 | 2015 | 699 | 0.650 |
Why?
|
| Muscle, Smooth | 6 | 2015 | 927 | 0.640 |
Why?
|
| Receptors, IgE | 3 | 2011 | 375 | 0.640 |
Why?
|
| Genome | 5 | 2024 | 1737 | 0.640 |
Why?
|
| Infant, Newborn | 53 | 2024 | 26183 | 0.640 |
Why?
|
| Pregnancy Complications | 8 | 2023 | 2948 | 0.630 |
Why?
|
| Stress, Mechanical | 3 | 2022 | 1674 | 0.630 |
Why?
|
| Airway Remodeling | 1 | 2020 | 133 | 0.630 |
Why?
|
| Bayes Theorem | 11 | 2022 | 2327 | 0.620 |
Why?
|
| Metabolome | 9 | 2024 | 988 | 0.620 |
Why?
|
| Alleles | 29 | 2021 | 6861 | 0.610 |
Why?
|
| Jews | 8 | 1999 | 356 | 0.610 |
Why?
|
| Disease | 2 | 2021 | 670 | 0.610 |
Why?
|
| Quantitative Trait Loci | 15 | 2022 | 2112 | 0.600 |
Why?
|
| Infant | 76 | 2024 | 36157 | 0.600 |
Why?
|
| Body Mass Index | 43 | 2024 | 12942 | 0.600 |
Why?
|
| Pyroglyphidae | 4 | 2012 | 89 | 0.600 |
Why?
|
| Autoimmune Diseases | 5 | 2014 | 2238 | 0.600 |
Why?
|
| Bronchoconstriction | 8 | 2016 | 142 | 0.590 |
Why?
|
| Receptors, Glucocorticoid | 4 | 2017 | 305 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 17 | 4 | 2019 | 418 | 0.580 |
Why?
|
| Subarachnoid Hemorrhage | 6 | 2024 | 1033 | 0.580 |
Why?
|
| Receptors, Cell Surface | 9 | 2009 | 2802 | 0.570 |
Why?
|
| Algorithms | 32 | 2024 | 14024 | 0.570 |
Why?
|
| Obesity | 32 | 2023 | 12934 | 0.570 |
Why?
|
| Infant, Premature | 7 | 2020 | 2107 | 0.570 |
Why?
|
| Gene Expression | 12 | 2020 | 7569 | 0.570 |
Why?
|
| Cathelicidins | 1 | 2017 | 80 | 0.570 |
Why?
|
| RNA, Ribosomal, 16S | 7 | 2023 | 1033 | 0.560 |
Why?
|
| Feces | 8 | 2022 | 1490 | 0.560 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 705 | 0.550 |
Why?
|
| Models, Genetic | 26 | 2022 | 3431 | 0.550 |
Why?
|
| Aged | 206 | 2024 | 169092 | 0.550 |
Why?
|
| Regression Analysis | 50 | 2013 | 6339 | 0.550 |
Why?
|
| Maternal Exposure | 9 | 2020 | 1067 | 0.540 |
Why?
|
| Linear Models | 31 | 2024 | 5866 | 0.540 |
Why?
|
| Proteins | 10 | 2020 | 6030 | 0.540 |
Why?
|
| Religion and Psychology | 6 | 1995 | 180 | 0.540 |
Why?
|
| Pneumonia | 5 | 2024 | 2143 | 0.540 |
Why?
|
| Genetic Testing | 17 | 2022 | 3533 | 0.530 |
Why?
|
| Dust | 6 | 2015 | 487 | 0.530 |
Why?
|
| T-Box Domain Proteins | 4 | 2019 | 469 | 0.530 |
Why?
|
| Bacteria | 8 | 2020 | 2192 | 0.520 |
Why?
|
| Severity of Illness Index | 49 | 2024 | 15829 | 0.520 |
Why?
|
| Epigenesis, Genetic | 10 | 2023 | 3794 | 0.520 |
Why?
|
| Islam | 7 | 1997 | 71 | 0.510 |
Why?
|
| Cytokines | 17 | 2023 | 7373 | 0.510 |
Why?
|
| Membrane Proteins | 11 | 2019 | 7847 | 0.510 |
Why?
|
| Steroids | 11 | 2021 | 928 | 0.500 |
Why?
|
| Antigens, Dermatophagoides | 12 | 2017 | 98 | 0.500 |
Why?
|
| Models, Biological | 15 | 2016 | 9461 | 0.500 |
Why?
|
| Prospective Studies | 82 | 2023 | 54364 | 0.500 |
Why?
|
| Pedigree | 19 | 2020 | 4539 | 0.490 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 122 | 0.490 |
Why?
|
| Neoplasm Proteins | 8 | 2024 | 3607 | 0.490 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 4 | 2023 | 88 | 0.480 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2023 | 1390 | 0.480 |
Why?
|
| Leukocytes, Mononuclear | 11 | 2020 | 1834 | 0.470 |
Why?
|
| Animals | 114 | 2024 | 168202 | 0.470 |
Why?
|
| Genetic Association Studies | 13 | 2021 | 2734 | 0.470 |
Why?
|
| Glucocorticoids | 10 | 2017 | 2160 | 0.470 |
Why?
|
| Hydroxyurea | 3 | 2018 | 282 | 0.470 |
Why?
|
| Health Surveys | 12 | 2009 | 4036 | 0.470 |
Why?
|
| Nuclear Family | 8 | 2008 | 311 | 0.460 |
Why?
|
| Genes, Developmental | 1 | 2014 | 38 | 0.460 |
Why?
|
| Coronary Disease | 15 | 2002 | 5911 | 0.460 |
Why?
|
| Hostility | 4 | 2006 | 183 | 0.460 |
Why?
|
| Area Under Curve | 7 | 2024 | 1635 | 0.450 |
Why?
|
| Air Pollution, Indoor | 11 | 2020 | 900 | 0.450 |
Why?
|
| Sarcoma, Experimental | 1 | 2013 | 116 | 0.450 |
Why?
|
| MMPI | 4 | 2003 | 81 | 0.440 |
Why?
|
| Sex Characteristics | 11 | 2016 | 2637 | 0.440 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2013 | 58 | 0.440 |
Why?
|
| Interleukin-10 | 8 | 2009 | 1171 | 0.440 |
Why?
|
| Salmonidae | 2 | 2003 | 13 | 0.440 |
Why?
|
| Biological Specimen Banks | 5 | 2021 | 778 | 0.440 |
Why?
|
| Mothers | 11 | 2023 | 2194 | 0.430 |
Why?
|
| Respiratory Insufficiency | 4 | 2022 | 1230 | 0.430 |
Why?
|
| Integrin beta Chains | 1 | 2013 | 115 | 0.430 |
Why?
|
| Diet | 21 | 2024 | 8049 | 0.430 |
Why?
|
| Endophenotypes | 1 | 2015 | 255 | 0.430 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 40 | 0.430 |
Why?
|
| Respiration | 9 | 2008 | 1656 | 0.420 |
Why?
|
| Fetus | 4 | 2023 | 1862 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2022 | 10203 | 0.420 |
Why?
|
| Rhinovirus | 4 | 2018 | 203 | 0.420 |
Why?
|
| Cross-Sectional Studies | 67 | 2024 | 26065 | 0.410 |
Why?
|
| Age Factors | 57 | 2021 | 18381 | 0.410 |
Why?
|
| NFATC Transcription Factors | 3 | 2020 | 389 | 0.410 |
Why?
|
| Neoplasms, Experimental | 2 | 2015 | 1226 | 0.410 |
Why?
|
| Receptors, Calcitriol | 5 | 2024 | 360 | 0.410 |
Why?
|
| Logistic Models | 42 | 2024 | 13248 | 0.410 |
Why?
|
| Genetic Markers | 22 | 2015 | 2601 | 0.410 |
Why?
|
| Models, Statistical | 16 | 2021 | 5074 | 0.410 |
Why?
|
| Aged, 80 and over | 84 | 2024 | 58919 | 0.410 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2008 | 540 | 0.410 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2013 | 163 | 0.400 |
Why?
|
| Family | 20 | 2024 | 3193 | 0.400 |
Why?
|
| Incidence | 29 | 2020 | 21339 | 0.400 |
Why?
|
| Aspirin | 4 | 2020 | 3127 | 0.400 |
Why?
|
| Gestational Age | 12 | 2023 | 3577 | 0.400 |
Why?
|
| Blood Pressure | 26 | 2014 | 8473 | 0.400 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 347 | 0.400 |
Why?
|
| Th2 Cells | 6 | 2024 | 1056 | 0.400 |
Why?
|
| Cyprinidae | 1 | 2011 | 37 | 0.390 |
Why?
|
| Rhinitis, Allergic, Seasonal | 7 | 2017 | 104 | 0.390 |
Why?
|
| Multivariate Analysis | 43 | 2020 | 12043 | 0.390 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 2011 | 790 | 0.390 |
Why?
|
| Fibrosarcoma | 1 | 2013 | 308 | 0.390 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 7583 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2016 | 3606 | 0.380 |
Why?
|
| Interferon-beta | 1 | 2013 | 345 | 0.380 |
Why?
|
| Autophagy | 3 | 2017 | 1327 | 0.380 |
Why?
|
| China | 19 | 2021 | 2374 | 0.380 |
Why?
|
| Maximal Midexpiratory Flow Rate | 7 | 2004 | 76 | 0.380 |
Why?
|
| Long-Term Care | 1 | 2015 | 631 | 0.380 |
Why?
|
| Databases, Genetic | 9 | 2021 | 1742 | 0.380 |
Why?
|
| Air Pollutants | 6 | 2019 | 2893 | 0.380 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2012 | 115 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 9 | 2019 | 2013 | 0.380 |
Why?
|
| Interferon Regulatory Factors | 3 | 2019 | 261 | 0.380 |
Why?
|
| Odds Ratio | 27 | 2020 | 9644 | 0.370 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 390 | 0.370 |
Why?
|
| Host-Pathogen Interactions | 4 | 2017 | 1454 | 0.370 |
Why?
|
| Acetates | 3 | 2012 | 321 | 0.370 |
Why?
|
| Mexican Americans | 6 | 2022 | 163 | 0.370 |
Why?
|
| Cell Line | 23 | 2024 | 15577 | 0.360 |
Why?
|
| Inflammation | 16 | 2024 | 10759 | 0.360 |
Why?
|
| Young Adult | 42 | 2022 | 59191 | 0.360 |
Why?
|
| Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
| Metagenomics | 4 | 2023 | 463 | 0.360 |
Why?
|
| Respiratory Tract Infections | 14 | 2006 | 1009 | 0.360 |
Why?
|
| Virus Diseases | 3 | 2015 | 718 | 0.360 |
Why?
|
| Gastrointestinal Tract | 2 | 2020 | 834 | 0.360 |
Why?
|
| Treatment Outcome | 53 | 2024 | 64572 | 0.360 |
Why?
|
| Principal Component Analysis | 7 | 2021 | 943 | 0.360 |
Why?
|
| Child Development | 3 | 2023 | 2300 | 0.360 |
Why?
|
| Cystic Fibrosis | 4 | 2009 | 1285 | 0.360 |
Why?
|
| Epithelium | 3 | 2021 | 1603 | 0.350 |
Why?
|
| Respiration Disorders | 7 | 1997 | 367 | 0.350 |
Why?
|
| Body Constitution | 8 | 2001 | 273 | 0.350 |
Why?
|
| Research Design | 16 | 2015 | 6174 | 0.350 |
Why?
|
| Fetal Development | 5 | 2020 | 769 | 0.350 |
Why?
|
| Riluzole | 1 | 2010 | 59 | 0.350 |
Why?
|
| Melanoma, Experimental | 1 | 2013 | 561 | 0.350 |
Why?
|
| Placenta | 6 | 2023 | 1709 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 2270 | 0.350 |
Why?
|
| Mice | 51 | 2024 | 81368 | 0.350 |
Why?
|
| C-Reactive Protein | 8 | 2023 | 3820 | 0.350 |
Why?
|
| Christianity | 4 | 1995 | 50 | 0.350 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2010 | 350 | 0.340 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 6 | 2021 | 323 | 0.340 |
Why?
|
| Basilar Artery | 2 | 2021 | 205 | 0.340 |
Why?
|
| Biofilms | 1 | 2014 | 626 | 0.340 |
Why?
|
| Alcoholism | 9 | 1995 | 1972 | 0.340 |
Why?
|
| Membrane Glycoproteins | 7 | 2011 | 3688 | 0.330 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2009 | 93 | 0.330 |
Why?
|
| Chondrogenesis | 2 | 2011 | 238 | 0.330 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.330 |
Why?
|
| Nurse-Patient Relations | 1 | 2009 | 99 | 0.330 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1890 | 0.330 |
Why?
|
| Cluster Analysis | 9 | 2022 | 2703 | 0.330 |
Why?
|
| CpG Islands | 9 | 2024 | 1192 | 0.330 |
Why?
|
| Body Height | 14 | 2024 | 1565 | 0.330 |
Why?
|
| Multifactorial Inheritance | 4 | 2023 | 1381 | 0.320 |
Why?
|
| Circle of Willis | 4 | 2023 | 78 | 0.320 |
Why?
|
| Medical Records Systems, Computerized | 4 | 2009 | 1191 | 0.320 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2024 | 365 | 0.320 |
Why?
|
| ROC Curve | 7 | 2020 | 3575 | 0.320 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 76 | 0.320 |
Why?
|
| Karyopherins | 1 | 2009 | 133 | 0.310 |
Why?
|
| Insulin | 12 | 2000 | 6593 | 0.310 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2014 | 1272 | 0.310 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2010 | 327 | 0.310 |
Why?
|
| Natural Language Processing | 5 | 2020 | 1166 | 0.310 |
Why?
|
| Integrin beta3 | 1 | 2009 | 120 | 0.310 |
Why?
|
| Multiple Organ Failure | 2 | 2022 | 387 | 0.310 |
Why?
|
| Follow-Up Studies | 55 | 2020 | 39062 | 0.310 |
Why?
|
| Histamine | 13 | 2000 | 499 | 0.310 |
Why?
|
| Sodium Channels | 1 | 2010 | 339 | 0.310 |
Why?
|
| RNA, Messenger | 17 | 2023 | 12759 | 0.310 |
Why?
|
| Fluocinolone Acetonide | 2 | 2009 | 38 | 0.310 |
Why?
|
| Immunoglobulins | 1 | 2011 | 850 | 0.310 |
Why?
|
| Israel | 16 | 1999 | 716 | 0.310 |
Why?
|
| Helminthiasis | 2 | 2000 | 81 | 0.300 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3115 | 0.300 |
Why?
|
| Sex Factors | 35 | 2016 | 10549 | 0.300 |
Why?
|
| Arginase | 1 | 2008 | 78 | 0.300 |
Why?
|
| Predictive Value of Tests | 30 | 2024 | 15250 | 0.300 |
Why?
|
| Vitamin E Deficiency | 1 | 2008 | 30 | 0.300 |
Why?
|
| Reference Values | 22 | 2012 | 4919 | 0.300 |
Why?
|
| Body Weight | 9 | 2011 | 4615 | 0.300 |
Why?
|
| Dexamethasone | 6 | 2018 | 1946 | 0.300 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 120 | 0.300 |
Why?
|
| Electronic Health Records | 7 | 2022 | 4810 | 0.290 |
Why?
|
| Risk | 32 | 2020 | 9603 | 0.290 |
Why?
|
| Drug Labeling | 1 | 2010 | 248 | 0.290 |
Why?
|
| Neutrophils | 5 | 2014 | 3763 | 0.290 |
Why?
|
| Drug Resistance | 5 | 2019 | 1594 | 0.290 |
Why?
|
| Interleukin-1 | 2 | 2009 | 1248 | 0.290 |
Why?
|
| Picornaviridae Infections | 3 | 2017 | 95 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 6 | 2014 | 7403 | 0.290 |
Why?
|
| Insulin Resistance | 6 | 1998 | 3954 | 0.290 |
Why?
|
| Haploidy | 1 | 2007 | 126 | 0.290 |
Why?
|
| Recurrence | 17 | 2020 | 8426 | 0.280 |
Why?
|
| Alcohol-Related Disorders | 2 | 2000 | 238 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 16 | 2017 | 5780 | 0.280 |
Why?
|
| Inservice Training | 1 | 2009 | 375 | 0.280 |
Why?
|
| Chemokines, CC | 2 | 2006 | 283 | 0.280 |
Why?
|
| Fatty Acids | 6 | 2023 | 1808 | 0.280 |
Why?
|
| Methacholine Compounds | 5 | 1990 | 35 | 0.280 |
Why?
|
| Quinolines | 3 | 2012 | 764 | 0.280 |
Why?
|
| Data Interpretation, Statistical | 11 | 2019 | 2689 | 0.280 |
Why?
|
| Attitude to Health | 3 | 2009 | 2025 | 0.280 |
Why?
|
| Base Sequence | 16 | 2023 | 12420 | 0.270 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2010 | 481 | 0.270 |
Why?
|
| Capnography | 2 | 2024 | 91 | 0.270 |
Why?
|
| Analysis of Variance | 20 | 2015 | 6223 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 3 | 2019 | 1602 | 0.270 |
Why?
|
| Boston | 32 | 2016 | 9313 | 0.270 |
Why?
|
| Family Health | 9 | 2006 | 1253 | 0.270 |
Why?
|
| Placebos | 9 | 2017 | 1667 | 0.270 |
Why?
|
| United States | 62 | 2023 | 72292 | 0.270 |
Why?
|
| Disease Susceptibility | 5 | 2019 | 1788 | 0.270 |
Why?
|
| Physician-Patient Relations | 3 | 2009 | 3239 | 0.270 |
Why?
|
| Germ-Line Mutation | 4 | 2023 | 1852 | 0.270 |
Why?
|
| Endotoxins | 3 | 2004 | 520 | 0.260 |
Why?
|
| Clostridium Infections | 3 | 2023 | 557 | 0.260 |
Why?
|
| Nose | 2 | 2020 | 521 | 0.260 |
Why?
|
| Clinical Trials as Topic | 12 | 2023 | 7995 | 0.260 |
Why?
|
| Sepsis | 4 | 2022 | 2585 | 0.260 |
Why?
|
| Lectins, C-Type | 1 | 2009 | 584 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 3 | 2020 | 1614 | 0.260 |
Why?
|
| Lod Score | 8 | 2006 | 600 | 0.260 |
Why?
|
| Interferons | 3 | 2022 | 702 | 0.250 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 393 | 0.250 |
Why?
|
| Eicosanoids | 2 | 2024 | 282 | 0.250 |
Why?
|
| Managed Care Programs | 6 | 2005 | 937 | 0.250 |
Why?
|
| Fish Oils | 2 | 2019 | 483 | 0.250 |
Why?
|
| Sunlight | 1 | 2007 | 337 | 0.250 |
Why?
|
| Wnt Proteins | 1 | 2009 | 718 | 0.250 |
Why?
|
| Computer Simulation | 19 | 2023 | 6233 | 0.250 |
Why?
|
| Interleukin-8 | 3 | 2023 | 696 | 0.250 |
Why?
|
| Interleukin-9 | 2 | 2016 | 62 | 0.250 |
Why?
|
| Artificial Intelligence | 2 | 2011 | 2575 | 0.250 |
Why?
|
| Ascorbic Acid | 5 | 2005 | 655 | 0.250 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 93 | 0.250 |
Why?
|
| Temperance | 2 | 1995 | 87 | 0.250 |
Why?
|
| Communication | 1 | 2019 | 3851 | 0.250 |
Why?
|
| Chromosomes, Human | 3 | 2018 | 441 | 0.250 |
Why?
|
| Epidemics | 1 | 2011 | 512 | 0.250 |
Why?
|
| Breast Feeding | 9 | 2018 | 1355 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2024 | 3776 | 0.240 |
Why?
|
| beta-Defensins | 1 | 2005 | 59 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2022 | 1650 | 0.240 |
Why?
|
| Chondrocytes | 1 | 2010 | 792 | 0.240 |
Why?
|
| Cardiovascular Diseases | 16 | 2023 | 15498 | 0.240 |
Why?
|
| Reproducibility of Results | 18 | 2024 | 20077 | 0.240 |
Why?
|
| Quantum Dots | 2 | 2009 | 167 | 0.240 |
Why?
|
| Lead Poisoning | 6 | 2003 | 322 | 0.240 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2630 | 0.230 |
Why?
|
| Diet Records | 2 | 2024 | 427 | 0.230 |
Why?
|
| Cerebral Angiography | 5 | 2021 | 1281 | 0.230 |
Why?
|
| Interferon-gamma | 6 | 2006 | 3145 | 0.230 |
Why?
|
| Microsatellite Repeats | 4 | 2011 | 783 | 0.230 |
Why?
|
| Folic Acid | 4 | 2017 | 1323 | 0.230 |
Why?
|
| Dietary Fats | 4 | 2018 | 1995 | 0.230 |
Why?
|
| Cotinine | 5 | 2022 | 206 | 0.230 |
Why?
|
| ADAM Proteins | 6 | 2007 | 238 | 0.230 |
Why?
|
| Sample Size | 6 | 2023 | 838 | 0.230 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2019 | 57 | 0.230 |
Why?
|
| Multigene Family | 3 | 2005 | 1076 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2020 | 2863 | 0.230 |
Why?
|
| Models, Theoretical | 13 | 2020 | 3567 | 0.230 |
Why?
|
| Physical Examination | 2 | 2004 | 1254 | 0.230 |
Why?
|
| Internet | 4 | 2014 | 3094 | 0.220 |
Why?
|
| Middle Cerebral Artery | 2 | 2023 | 274 | 0.220 |
Why?
|
| Caffeine | 2 | 2022 | 699 | 0.220 |
Why?
|
| Fibroblasts | 8 | 2016 | 4140 | 0.220 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 149 | 0.220 |
Why?
|
| Airway Obstruction | 4 | 2012 | 661 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2004 | 386 | 0.220 |
Why?
|
| Prevalence | 23 | 2022 | 15702 | 0.220 |
Why?
|
| Communicable Diseases | 2 | 2022 | 871 | 0.220 |
Why?
|
| Oscillometry | 1 | 2024 | 150 | 0.220 |
Why?
|
| Immunity, Innate | 9 | 2019 | 3045 | 0.220 |
Why?
|
| Shoulder Dislocation | 1 | 2004 | 129 | 0.220 |
Why?
|
| Brain Ischemia | 2 | 2019 | 3030 | 0.210 |
Why?
|
| Diabetes, Gestational | 2 | 2023 | 1250 | 0.210 |
Why?
|
| Wood | 2 | 2014 | 92 | 0.210 |
Why?
|
| Repression, Psychology | 1 | 2003 | 46 | 0.210 |
Why?
|
| Adjustment Disorders | 1 | 2003 | 67 | 0.210 |
Why?
|
| Magnesium | 2 | 2018 | 804 | 0.210 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 219 | 0.210 |
Why?
|
| Metagenome | 3 | 2022 | 448 | 0.210 |
Why?
|
| rho-Associated Kinases | 1 | 2024 | 281 | 0.210 |
Why?
|
| Signal Transduction | 14 | 2024 | 23415 | 0.210 |
Why?
|
| Ecosystem | 2 | 2017 | 487 | 0.210 |
Why?
|
| Lipids | 6 | 2020 | 3332 | 0.210 |
Why?
|
| Myostatin | 1 | 2023 | 129 | 0.210 |
Why?
|
| Bronchitis | 4 | 1998 | 196 | 0.210 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 846 | 0.200 |
Why?
|
| Patients | 1 | 2009 | 906 | 0.200 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2016 | 326 | 0.200 |
Why?
|
| Puerto Rico | 7 | 2021 | 378 | 0.200 |
Why?
|
| Risk Assessment | 16 | 2019 | 23974 | 0.200 |
Why?
|
| Benchmarking | 3 | 2023 | 1045 | 0.200 |
Why?
|
| Anger | 3 | 2006 | 406 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2014 | 2149 | 0.200 |
Why?
|
| Time Factors | 36 | 2015 | 39908 | 0.200 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 994 | 0.200 |
Why?
|
| Sympathetic Nervous System | 3 | 1996 | 519 | 0.200 |
Why?
|
| Bacterial Toxins | 2 | 1998 | 925 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2002 | 127 | 0.200 |
Why?
|
| Vasospasm, Intracranial | 1 | 2024 | 214 | 0.200 |
Why?
|
| Lymphocytes | 4 | 2019 | 2604 | 0.200 |
Why?
|
| Heat-Shock Proteins | 3 | 2009 | 795 | 0.200 |
Why?
|
| Disease Progression | 16 | 2019 | 13495 | 0.200 |
Why?
|
| Patient Satisfaction | 4 | 2009 | 3451 | 0.200 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2002 | 59 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 4 | 2017 | 1962 | 0.200 |
Why?
|
| Immunotherapy | 1 | 2017 | 4642 | 0.200 |
Why?
|
| Insect Proteins | 3 | 2006 | 254 | 0.200 |
Why?
|
| Tenascin | 1 | 2022 | 61 | 0.200 |
Why?
|
| Interleukin-12 | 1 | 2004 | 577 | 0.190 |
Why?
|
| Mucin-1 | 2 | 2023 | 538 | 0.190 |
Why?
|
| Vitamin E | 5 | 2008 | 872 | 0.190 |
Why?
|
| Tryptophan | 2 | 2024 | 482 | 0.190 |
Why?
|
| Immunoglobulin Joining Region | 1 | 2001 | 37 | 0.190 |
Why?
|
| Cell Shape | 2 | 2015 | 369 | 0.190 |
Why?
|
| RNA | 4 | 2021 | 2713 | 0.190 |
Why?
|
| Rural Health | 2 | 2001 | 296 | 0.190 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2001 | 58 | 0.190 |
Why?
|
| Parents | 8 | 2010 | 3563 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3492 | 0.190 |
Why?
|
| DNA | 5 | 2021 | 7196 | 0.190 |
Why?
|
| DNA-Binding Proteins | 10 | 2020 | 9586 | 0.190 |
Why?
|
| Database Management Systems | 1 | 2003 | 257 | 0.190 |
Why?
|
| Pregnancy Tests | 1 | 2001 | 33 | 0.190 |
Why?
|
| Prognosis | 26 | 2023 | 29601 | 0.190 |
Why?
|
| Respiratory Mucosa | 2 | 2016 | 438 | 0.190 |
Why?
|
| Immune System | 3 | 2017 | 791 | 0.190 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2001 | 82 | 0.190 |
Why?
|
| Bronchial Spasm | 4 | 1990 | 71 | 0.190 |
Why?
|
| Hydrocortisone | 6 | 2024 | 1819 | 0.190 |
Why?
|
| Uric Acid | 4 | 2006 | 806 | 0.190 |
Why?
|
| Geography | 1 | 2003 | 652 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 12143 | 0.190 |
Why?
|
| Compressive Strength | 1 | 2022 | 158 | 0.190 |
Why?
|
| Biological Therapy | 1 | 2022 | 139 | 0.190 |
Why?
|
| Chorioamnionitis | 2 | 2020 | 156 | 0.190 |
Why?
|
| Cell Movement | 5 | 2024 | 5201 | 0.180 |
Why?
|
| Genes | 4 | 1999 | 1823 | 0.180 |
Why?
|
| HLA-A2 Antigen | 1 | 2021 | 209 | 0.180 |
Why?
|
| Phylogeny | 6 | 2021 | 2805 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2017 | 699 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2019 | 4365 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 1 | 2005 | 871 | 0.180 |
Why?
|
| Maternal Behavior | 2 | 2012 | 307 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2018 | 10754 | 0.180 |
Why?
|
| Oligonucleotides | 2 | 2021 | 566 | 0.180 |
Why?
|
| Hemolysin Proteins | 2 | 1998 | 113 | 0.180 |
Why?
|
| Carrier Proteins | 7 | 2019 | 4937 | 0.180 |
Why?
|
| Adipose Tissue | 8 | 2016 | 3310 | 0.180 |
Why?
|
| Fucosyltransferases | 1 | 2020 | 117 | 0.180 |
Why?
|
| DNA, Mitochondrial | 2 | 2003 | 865 | 0.180 |
Why?
|
| Rhinitis | 3 | 2002 | 747 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 6188 | 0.180 |
Why?
|
| Alkanesulfonic Acids | 1 | 2023 | 201 | 0.180 |
Why?
|
| Maternal Age | 4 | 2020 | 809 | 0.180 |
Why?
|
| Urban Population | 9 | 2009 | 2034 | 0.170 |
Why?
|
| Common Cold | 2 | 2018 | 63 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 5 | 2015 | 630 | 0.170 |
Why?
|
| Medically Underserved Area | 1 | 2022 | 254 | 0.170 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2010 | 44 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2020 | 2872 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2008 | 4340 | 0.170 |
Why?
|
| Population Surveillance | 8 | 2020 | 2597 | 0.170 |
Why?
|
| Abortion, Legal | 1 | 2001 | 113 | 0.170 |
Why?
|
| Emergency Service, Hospital | 10 | 2014 | 7873 | 0.170 |
Why?
|
| Chromatography, Liquid | 5 | 2023 | 982 | 0.170 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2000 | 82 | 0.170 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 179 | 0.170 |
Why?
|
| Disease Management | 5 | 2020 | 2506 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 9 | 2024 | 7390 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2013 | 604 | 0.170 |
Why?
|
| Antioxidants | 5 | 2006 | 1669 | 0.170 |
Why?
|
| Nitrogen Dioxide | 3 | 2019 | 522 | 0.170 |
Why?
|
| Splints | 1 | 2000 | 108 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2018 | 3245 | 0.170 |
Why?
|
| Transcription Factors | 10 | 2016 | 12116 | 0.170 |
Why?
|
| Cats | 8 | 2003 | 974 | 0.170 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2017 | 1360 | 0.170 |
Why?
|
| Muscle Contraction | 1 | 2004 | 1200 | 0.170 |
Why?
|
| Calcitriol | 2 | 2012 | 296 | 0.170 |
Why?
|
| Down-Regulation | 6 | 2024 | 2916 | 0.170 |
Why?
|
| Hypertension | 14 | 2006 | 8532 | 0.160 |
Why?
|
| Glycine Hydroxymethyltransferase | 2 | 2012 | 32 | 0.160 |
Why?
|
| Paraproteinemias | 1 | 2022 | 248 | 0.160 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 1642 | 0.160 |
Why?
|
| Immunization | 2 | 2017 | 1217 | 0.160 |
Why?
|
| beta-Globins | 1 | 2019 | 111 | 0.160 |
Why?
|
| Ethanolamines | 1 | 2019 | 153 | 0.160 |
Why?
|
| Lysine | 1 | 2024 | 993 | 0.160 |
Why?
|
| Cockroaches | 9 | 2006 | 97 | 0.160 |
Why?
|
| Physicians, Family | 3 | 2009 | 348 | 0.160 |
Why?
|
| Chorionic Gonadotropin | 1 | 2001 | 457 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2003 | 1434 | 0.160 |
Why?
|
| Haemophilus influenzae | 1 | 2019 | 178 | 0.160 |
Why?
|
| Desensitization, Immunologic | 1 | 2024 | 556 | 0.160 |
Why?
|
| Metals, Heavy | 1 | 2020 | 148 | 0.160 |
Why?
|
| Carbon Dioxide | 2 | 2023 | 1148 | 0.160 |
Why?
|
| Statistics as Topic | 5 | 2016 | 2358 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 2 | 2023 | 865 | 0.160 |
Why?
|
| Hemolysis | 1 | 2021 | 415 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4569 | 0.160 |
Why?
|
| Austria | 3 | 2015 | 206 | 0.160 |
Why?
|
| Type A Personality | 1 | 1998 | 24 | 0.160 |
Why?
|
| Placebo Effect | 2 | 2020 | 518 | 0.160 |
Why?
|
| Age Distribution | 12 | 2009 | 2872 | 0.160 |
Why?
|
| Molecular Sequence Data | 11 | 2011 | 17630 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 7 | 2017 | 1700 | 0.160 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 413 | 0.160 |
Why?
|
| Homocysteine | 2 | 2012 | 637 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2018 | 247 | 0.160 |
Why?
|
| Nasal Mucosa | 2 | 2020 | 415 | 0.160 |
Why?
|
| Health Education | 3 | 1995 | 1049 | 0.160 |
Why?
|
| Carbon Monoxide | 3 | 2019 | 547 | 0.160 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 350 | 0.160 |
Why?
|
| Murine hepatitis virus | 2 | 1995 | 19 | 0.150 |
Why?
|
| 3' Untranslated Regions | 4 | 2014 | 516 | 0.150 |
Why?
|
| Body Composition | 6 | 1997 | 2426 | 0.150 |
Why?
|
| Hand Strength | 2 | 2000 | 456 | 0.150 |
Why?
|
| Telomere | 2 | 2024 | 942 | 0.150 |
Why?
|
| Interleukin-2 | 2 | 2024 | 1888 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2018 | 145 | 0.150 |
Why?
|
| Educational Status | 7 | 2023 | 2509 | 0.150 |
Why?
|
| Thumb | 1 | 2000 | 232 | 0.150 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 380 | 0.150 |
Why?
|
| Fracture Healing | 2 | 2011 | 445 | 0.150 |
Why?
|
| Helminths | 1 | 1998 | 39 | 0.150 |
Why?
|
| Cerebellar Nuclei | 1 | 2018 | 51 | 0.150 |
Why?
|
| Statistics, Nonparametric | 2 | 2003 | 2851 | 0.150 |
Why?
|
| Netherlands | 17 | 2016 | 2222 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 744 | 0.150 |
Why?
|
| Vitamin D-Binding Protein | 2 | 2021 | 131 | 0.150 |
Why?
|
| Pulmonary Alveoli | 3 | 2010 | 652 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2022 | 349 | 0.150 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 1587 | 0.150 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2007 | 1348 | 0.150 |
Why?
|
| Body Image | 1 | 2003 | 639 | 0.150 |
Why?
|
| Measles | 1 | 2000 | 181 | 0.150 |
Why?
|
| Population Density | 3 | 2021 | 193 | 0.150 |
Why?
|
| Problem Solving | 1 | 2020 | 444 | 0.150 |
Why?
|
| Antigen Presentation | 3 | 1998 | 1250 | 0.150 |
Why?
|
| Women | 1 | 1999 | 224 | 0.150 |
Why?
|
| Species Specificity | 3 | 2017 | 2410 | 0.150 |
Why?
|
| Cough | 7 | 2019 | 595 | 0.150 |
Why?
|
| Environmental Pollutants | 2 | 2023 | 1277 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2023 | 492 | 0.140 |
Why?
|
| Sphingosine | 1 | 2019 | 307 | 0.140 |
Why?
|
| Microbial Interactions | 1 | 2017 | 74 | 0.140 |
Why?
|
| Sputum | 2 | 2021 | 506 | 0.140 |
Why?
|
| Peptide Fragments | 1 | 2010 | 5109 | 0.140 |
Why?
|
| Bone and Bones | 9 | 2003 | 2565 | 0.140 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 819 | 0.140 |
Why?
|
| Calcitonin | 2 | 2008 | 329 | 0.140 |
Why?
|
| Cholesterol, HDL | 5 | 2018 | 1810 | 0.140 |
Why?
|
| Triclosan | 1 | 2017 | 58 | 0.140 |
Why?
|
| Fossil Fuels | 1 | 1997 | 53 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2019 | 337 | 0.140 |
Why?
|
| Internationality | 1 | 2022 | 1000 | 0.140 |
Why?
|
| Air Pollution | 4 | 2023 | 2355 | 0.140 |
Why?
|
| Epidemiologic Methods | 6 | 2001 | 1335 | 0.140 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 12448 | 0.140 |
Why?
|
| Genome, Viral | 1 | 2021 | 665 | 0.140 |
Why?
|
| Protein Precursors | 3 | 2008 | 1131 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 4 | 2015 | 552 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 22117 | 0.140 |
Why?
|
| Parabens | 1 | 2017 | 114 | 0.140 |
Why?
|
| Sensitivity and Specificity | 15 | 2024 | 14649 | 0.140 |
Why?
|
| Heroin Dependence | 1 | 2017 | 172 | 0.140 |
Why?
|
| Receptors, Immunologic | 3 | 2022 | 1409 | 0.140 |
Why?
|
| Sex Distribution | 9 | 2003 | 2278 | 0.140 |
Why?
|
| Genes, MHC Class I | 1 | 1997 | 235 | 0.140 |
Why?
|
| Globus Pallidus | 1 | 2018 | 250 | 0.140 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 381 | 0.140 |
Why?
|
| Immunomodulation | 2 | 2024 | 548 | 0.140 |
Why?
|
| Smoke | 2 | 2023 | 236 | 0.130 |
Why?
|
| Arabs | 1 | 1999 | 187 | 0.130 |
Why?
|
| Listeria monocytogenes | 1 | 1998 | 247 | 0.130 |
Why?
|
| Administration, Oral | 7 | 2024 | 4010 | 0.130 |
Why?
|
| Cell Differentiation | 7 | 2010 | 11512 | 0.130 |
Why?
|
| Glycolysis | 1 | 2020 | 835 | 0.130 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 1698 | 0.130 |
Why?
|
| Mites | 6 | 2002 | 46 | 0.130 |
Why?
|
| Primary Prevention | 2 | 2014 | 1185 | 0.130 |
Why?
|
| HLA Antigens | 3 | 2018 | 1327 | 0.130 |
Why?
|
| Child Day Care Centers | 3 | 2002 | 122 | 0.130 |
Why?
|
| Age of Onset | 8 | 2015 | 3303 | 0.130 |
Why?
|
| Databases, Factual | 5 | 2024 | 7963 | 0.130 |
Why?
|
| Leukotrienes | 4 | 2018 | 231 | 0.130 |
Why?
|
| Pneumococcal Infections | 1 | 2020 | 501 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2018 | 253 | 0.130 |
Why?
|
| Social Environment | 4 | 1994 | 1021 | 0.130 |
Why?
|
| Housing | 4 | 2005 | 669 | 0.130 |
Why?
|
| Delivery of Health Care | 7 | 2020 | 5334 | 0.130 |
Why?
|
| Socioeconomic Factors | 14 | 2012 | 7805 | 0.130 |
Why?
|
| Chronic Disease | 11 | 2016 | 9310 | 0.130 |
Why?
|
| Evolution, Molecular | 2 | 2003 | 1880 | 0.130 |
Why?
|
| Utilization Review | 2 | 2015 | 382 | 0.130 |
Why?
|
| Androgens | 1 | 2023 | 1285 | 0.130 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2015 | 45 | 0.130 |
Why?
|
| Resuscitation | 1 | 2000 | 672 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2014 | 370 | 0.130 |
Why?
|
| B-Lymphocytes | 3 | 2015 | 4745 | 0.130 |
Why?
|
| Serpin E2 | 3 | 2011 | 48 | 0.130 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 565 | 0.130 |
Why?
|
| Occupational Diseases | 8 | 2006 | 1490 | 0.130 |
Why?
|
| Cells, Cultured | 14 | 2018 | 18937 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2021 | 2118 | 0.130 |
Why?
|
| Proprotein Convertase 1 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Chemokines | 2 | 2020 | 954 | 0.130 |
Why?
|
| Hypertrophy | 2 | 2010 | 560 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2812 | 0.130 |
Why?
|
| Dermatophagoides farinae | 1 | 2015 | 19 | 0.130 |
Why?
|
| alpha Catenin | 1 | 2015 | 37 | 0.130 |
Why?
|
| Overweight | 3 | 2018 | 2417 | 0.130 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2011 | 175 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 3077 | 0.120 |
Why?
|
| Ankyrin Repeat | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cohort Effect | 1 | 1995 | 39 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 2896 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2015 | 313 | 0.120 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2015 | 53 | 0.120 |
Why?
|
| Office Visits | 4 | 2015 | 593 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 540 | 0.120 |
Why?
|
| Aneurysm | 1 | 2018 | 337 | 0.120 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 117 | 0.120 |
Why?
|
| Mice, Inbred DBA | 2 | 2015 | 619 | 0.120 |
Why?
|
| Bronchiolitis, Viral | 2 | 2014 | 82 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2017 | 352 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 2006 | 242 | 0.120 |
Why?
|
| Semaphorins | 1 | 2015 | 96 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 370 | 0.120 |
Why?
|
| Acetaminophen | 2 | 2014 | 555 | 0.120 |
Why?
|
| alpha-N-Acetylgalactosaminidase | 1 | 2014 | 4 | 0.120 |
Why?
|
| Mucus | 2 | 2019 | 342 | 0.120 |
Why?
|
| Anxiety | 4 | 2015 | 4573 | 0.120 |
Why?
|
| Anthropometry | 8 | 2022 | 1338 | 0.120 |
Why?
|
| Amides | 1 | 2017 | 449 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1998 | 1349 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 725 | 0.120 |
Why?
|
| Personality Development | 2 | 1992 | 244 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2004 | 1265 | 0.120 |
Why?
|
| Salmonella Infections, Animal | 1 | 2014 | 60 | 0.120 |
Why?
|
| Smoking Cessation | 3 | 2017 | 2056 | 0.120 |
Why?
|
| Drug Therapy | 2 | 2008 | 503 | 0.120 |
Why?
|
| Serotonin | 3 | 1998 | 1041 | 0.120 |
Why?
|
| Nutritional Status | 3 | 2023 | 1597 | 0.120 |
Why?
|
| Antibiosis | 1 | 2014 | 45 | 0.120 |
Why?
|
| International Classification of Diseases | 3 | 2016 | 912 | 0.120 |
Why?
|
| Fever | 3 | 2008 | 1618 | 0.120 |
Why?
|
| Shock, Septic | 1 | 2021 | 769 | 0.120 |
Why?
|
| Retrospective Studies | 25 | 2024 | 80583 | 0.120 |
Why?
|
| Stress, Psychological | 6 | 2015 | 4488 | 0.120 |
Why?
|
| Pacifiers | 1 | 2013 | 12 | 0.120 |
Why?
|
| Exons | 7 | 2018 | 2381 | 0.110 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 178 | 0.110 |
Why?
|
| Chemokine CXCL5 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Peak Expiratory Flow Rate | 6 | 2004 | 144 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2014 | 100 | 0.110 |
Why?
|
| Sulfides | 3 | 2012 | 169 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2000 | 1070 | 0.110 |
Why?
|
| Epinephrine | 3 | 1994 | 792 | 0.110 |
Why?
|
| Mitochondria | 1 | 2007 | 3619 | 0.110 |
Why?
|
| Proteomics | 2 | 2023 | 3836 | 0.110 |
Why?
|
| Critical Illness | 3 | 2022 | 2709 | 0.110 |
Why?
|
| Copper | 3 | 2005 | 367 | 0.110 |
Why?
|
| Europe | 4 | 2022 | 3415 | 0.110 |
Why?
|
| Hospitalization | 12 | 2022 | 10708 | 0.110 |
Why?
|
| beta 2-Microglobulin | 1 | 1995 | 328 | 0.110 |
Why?
|
| Alternative Splicing | 4 | 2016 | 1088 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1997 | 563 | 0.110 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 106 | 0.110 |
Why?
|
| Drug Administration Schedule | 8 | 2007 | 4845 | 0.110 |
Why?
|
| Cholesterol, LDL | 9 | 2018 | 2378 | 0.110 |
Why?
|
| T-Lymphocytes | 8 | 2020 | 10175 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2008 | 1217 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2019 | 944 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2049 | 0.110 |
Why?
|
| Calcium | 4 | 2018 | 5717 | 0.110 |
Why?
|
| Aspergillus niger | 1 | 2013 | 18 | 0.110 |
Why?
|
| Forecasting | 4 | 2015 | 2924 | 0.110 |
Why?
|
| Chemokine CXCL1 | 1 | 2013 | 101 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 208 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
| Environment | 5 | 2016 | 1123 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2012 | 350 | 0.110 |
Why?
|
| Data Collection | 5 | 2023 | 3316 | 0.110 |
Why?
|
| Cyclopropanes | 3 | 2012 | 432 | 0.110 |
Why?
|
| Leishmania major | 1 | 2013 | 59 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 610 | 0.110 |
Why?
|
| Confidence Intervals | 9 | 2017 | 2925 | 0.110 |
Why?
|
| Prednisolone | 1 | 2014 | 324 | 0.110 |
Why?
|
| Calcifediol | 3 | 2023 | 161 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 229 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2001 | 1754 | 0.110 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2015 | 450 | 0.110 |
Why?
|
| Thiophenes | 1 | 2017 | 569 | 0.110 |
Why?
|
| Self Report | 1 | 2024 | 3727 | 0.110 |
Why?
|
| Leukotriene E4 | 2 | 2012 | 75 | 0.100 |
Why?
|
| Biometry | 3 | 2007 | 561 | 0.100 |
Why?
|
| Weaning | 1 | 2013 | 103 | 0.100 |
Why?
|
| Hyperlipidemias | 2 | 2013 | 770 | 0.100 |
Why?
|
| gamma-Glutamyl Hydrolase | 1 | 2012 | 8 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2017 | 901 | 0.100 |
Why?
|
| Catecholamines | 1 | 1993 | 387 | 0.100 |
Why?
|
| Diabetes Mellitus | 3 | 2022 | 5838 | 0.100 |
Why?
|
| Mice, Inbred NOD | 2 | 2015 | 1827 | 0.100 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.100 |
Why?
|
| Porphobilinogen Synthase | 2 | 2003 | 27 | 0.100 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10429 | 0.100 |
Why?
|
| Systems Integration | 1 | 2014 | 426 | 0.100 |
Why?
|
| Phobic Disorders | 1 | 1995 | 439 | 0.100 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2018 | 461 | 0.100 |
Why?
|
| Liver | 5 | 2021 | 7512 | 0.100 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 276 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2020 | 1017 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 3 | 2012 | 1086 | 0.100 |
Why?
|
| HLA-DQ Antigens | 1 | 2012 | 190 | 0.100 |
Why?
|
| Arthrogryposis | 1 | 2013 | 68 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2000 | 1063 | 0.100 |
Why?
|
| Immobilization | 1 | 1993 | 229 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2021 | 14388 | 0.100 |
Why?
|
| Rural Population | 9 | 2002 | 2277 | 0.100 |
Why?
|
| Intubation, Intratracheal | 1 | 2000 | 1331 | 0.100 |
Why?
|
| Cadherins | 1 | 2017 | 901 | 0.100 |
Why?
|
| Cesarean Section | 3 | 2022 | 1396 | 0.100 |
Why?
|
| Bronchial Diseases | 3 | 1987 | 150 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 1333 | 0.100 |
Why?
|
| Physical Stimulation | 1 | 2013 | 517 | 0.100 |
Why?
|
| Heterozygote | 3 | 2021 | 2780 | 0.100 |
Why?
|
| Iron | 3 | 2019 | 1790 | 0.100 |
Why?
|
| Mass Spectrometry | 4 | 2022 | 2189 | 0.100 |
Why?
|
| Bony Callus | 1 | 2011 | 41 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2878 | 0.100 |
Why?
|
| Quality of Life | 7 | 2012 | 13359 | 0.100 |
Why?
|
| Fetal Proteins | 1 | 2012 | 98 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 249 | 0.100 |
Why?
|
| Fathers | 3 | 2005 | 375 | 0.100 |
Why?
|
| Cytochromes b | 1 | 2011 | 35 | 0.100 |
Why?
|
| Patient Compliance | 4 | 2010 | 2688 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3550 | 0.100 |
Why?
|
| Heart Rate | 3 | 2005 | 4181 | 0.100 |
Why?
|
| Solubility | 2 | 2008 | 1089 | 0.100 |
Why?
|
| Norepinephrine | 5 | 1996 | 898 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 1 | 1993 | 272 | 0.100 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2013 | 136 | 0.100 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 170 | 0.100 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2012 | 161 | 0.100 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2012 | 78 | 0.090 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2014 | 149 | 0.090 |
Why?
|
| STAT6 Transcription Factor | 1 | 2011 | 194 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2022 | 1521 | 0.090 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1991 | 3 | 0.090 |
Why?
|
| Zinc Fingers | 1 | 2013 | 578 | 0.090 |
Why?
|
| Kallikreins | 1 | 2012 | 220 | 0.090 |
Why?
|
| Fishes | 1 | 1994 | 602 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2021 | 4058 | 0.090 |
Why?
|
| Leukopenia | 1 | 1991 | 213 | 0.090 |
Why?
|
| Social Support | 3 | 2013 | 2174 | 0.090 |
Why?
|
| Cold Temperature | 8 | 1989 | 785 | 0.090 |
Why?
|
| Pulmonary Emphysema | 2 | 2015 | 684 | 0.090 |
Why?
|
| Classification | 1 | 2011 | 127 | 0.090 |
Why?
|
| Tandem Repeat Sequences | 2 | 2002 | 180 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2000 | 1375 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 1884 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2009 | 306 | 0.090 |
Why?
|
| Attitude | 3 | 1992 | 772 | 0.090 |
Why?
|
| Allylamine | 2 | 2001 | 10 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1899 | 0.090 |
Why?
|
| Posture | 2 | 1986 | 956 | 0.090 |
Why?
|
| Glycoproteins | 8 | 2008 | 2200 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2015 | 2894 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4739 | 0.090 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1990 | 35 | 0.090 |
Why?
|
| Electrocardiography | 7 | 2010 | 6346 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1276 | 0.090 |
Why?
|
| Likelihood Functions | 4 | 2016 | 991 | 0.090 |
Why?
|
| Ambulatory Care | 2 | 2001 | 2768 | 0.090 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 992 | 0.090 |
Why?
|
| Alcian Blue | 1 | 2010 | 13 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3527 | 0.090 |
Why?
|
| DNA Mutational Analysis | 6 | 2021 | 4110 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2016 | 3599 | 0.090 |
Why?
|
| Intestines | 2 | 2016 | 1909 | 0.090 |
Why?
|
| Biodiversity | 3 | 2018 | 345 | 0.090 |
Why?
|
| Primary Health Care | 3 | 2022 | 4677 | 0.090 |
Why?
|
| Collagen Type X | 1 | 2010 | 16 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1703 | 0.090 |
Why?
|
| Lung Volume Measurements | 6 | 1997 | 375 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2006 | 1111 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 1999 | 1972 | 0.090 |
Why?
|
| Leukocytosis | 1 | 1991 | 251 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2021 | 730 | 0.090 |
Why?
|
| alpha-2-Antiplasmin | 1 | 2010 | 13 | 0.090 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2010 | 56 | 0.090 |
Why?
|
| Perinatal Care | 1 | 2013 | 244 | 0.090 |
Why?
|
| Fluorescence | 2 | 2005 | 756 | 0.090 |
Why?
|
| Patella | 4 | 2007 | 315 | 0.090 |
Why?
|
| Bacterial Infections | 2 | 2008 | 1389 | 0.090 |
Why?
|
| Dogs | 5 | 2020 | 3837 | 0.090 |
Why?
|
| Methylprednisolone | 2 | 2008 | 385 | 0.090 |
Why?
|
| Plants, Toxic | 2 | 1996 | 71 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2010 | 15 | 0.090 |
Why?
|
| Alkaline Phosphatase | 3 | 2010 | 860 | 0.090 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1992 | 233 | 0.090 |
Why?
|
| Stem Cells | 2 | 2000 | 3514 | 0.090 |
Why?
|
| North America | 4 | 2021 | 1273 | 0.090 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3088 | 0.090 |
Why?
|
| Genes, MHC Class II | 1 | 1991 | 433 | 0.090 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2010 | 102 | 0.090 |
Why?
|
| Birth Weight | 5 | 2012 | 2101 | 0.090 |
Why?
|
| Family Nursing | 1 | 2009 | 20 | 0.090 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 393 | 0.090 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1991 | 285 | 0.090 |
Why?
|
| Warfarin | 1 | 2018 | 1477 | 0.090 |
Why?
|
| Egg Proteins | 1 | 2009 | 57 | 0.080 |
Why?
|
| Drug Design | 2 | 2005 | 1045 | 0.080 |
Why?
|
| Theophylline | 2 | 2008 | 131 | 0.080 |
Why?
|
| Epilepsy | 2 | 2022 | 3303 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2010 | 148 | 0.080 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2010 | 201 | 0.080 |
Why?
|
| Systole | 4 | 2003 | 935 | 0.080 |
Why?
|
| Nicotine | 1 | 2014 | 679 | 0.080 |
Why?
|
| Cost Savings | 1 | 2015 | 912 | 0.080 |
Why?
|
| Hypercholesterolemia | 4 | 2001 | 1141 | 0.080 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 3085 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 520 | 0.080 |
Why?
|
| Ionomycin | 1 | 2009 | 110 | 0.080 |
Why?
|
| Alendronate | 2 | 2001 | 175 | 0.080 |
Why?
|
| Serum Albumin | 1 | 1992 | 673 | 0.080 |
Why?
|
| Health Maintenance Organizations | 3 | 2001 | 658 | 0.080 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2021 | 335 | 0.080 |
Why?
|
| Fasting | 5 | 1998 | 1603 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2016 | 732 | 0.080 |
Why?
|
| Thrombospondins | 1 | 2010 | 193 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 1995 | 888 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 113 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3634 | 0.080 |
Why?
|
| Leukocytes | 2 | 2017 | 2024 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2014 | 802 | 0.080 |
Why?
|
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 358 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2004 | 638 | 0.080 |
Why?
|
| Comorbidity | 9 | 2017 | 10507 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2009 | 535 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2010 | 2625 | 0.080 |
Why?
|
| Heart Diseases | 2 | 2009 | 2778 | 0.080 |
Why?
|
| Triglycerides | 7 | 2000 | 2459 | 0.080 |
Why?
|
| Intermediate Filament Proteins | 2 | 2007 | 262 | 0.080 |
Why?
|
| Medication Therapy Management | 1 | 2010 | 130 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2423 | 0.080 |
Why?
|
| Azathioprine | 1 | 2010 | 354 | 0.080 |
Why?
|
| Sphingomyelins | 2 | 2023 | 105 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2014 | 1526 | 0.080 |
Why?
|
| Drug Utilization | 4 | 2005 | 1186 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 2 | 2012 | 1380 | 0.080 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2010 | 305 | 0.080 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1994 | 745 | 0.080 |
Why?
|
| Introns | 4 | 2009 | 968 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1589 | 0.080 |
Why?
|
| Receptors, Leukotriene | 1 | 2009 | 95 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2252 | 0.080 |
Why?
|
| Bone Density | 5 | 2012 | 3548 | 0.080 |
Why?
|
| Chemokine CCL11 | 2 | 2006 | 128 | 0.080 |
Why?
|
| Creatinine | 6 | 2003 | 1895 | 0.080 |
Why?
|
| Rats | 11 | 2012 | 23716 | 0.080 |
Why?
|
| Poly C | 1 | 2007 | 6 | 0.080 |
Why?
|
| Alcoholic Intoxication | 2 | 1990 | 174 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2008 | 428 | 0.080 |
Why?
|
| Canada | 4 | 2012 | 2120 | 0.080 |
Why?
|
| Deafness | 3 | 1998 | 459 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2004 | 3426 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2006 | 128 | 0.080 |
Why?
|
| Ion Channels | 1 | 2013 | 1039 | 0.080 |
Why?
|
| Immunoglobulin G | 3 | 2007 | 4533 | 0.070 |
Why?
|
| Verbal Learning | 1 | 1990 | 463 | 0.070 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 528 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9171 | 0.070 |
Why?
|
| Sampling Studies | 4 | 2003 | 615 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1998 | 4570 | 0.070 |
Why?
|
| Causality | 3 | 2001 | 1241 | 0.070 |
Why?
|
| Gene Order | 2 | 2007 | 169 | 0.070 |
Why?
|
| Indians, Central American | 1 | 2007 | 19 | 0.070 |
Why?
|
| Tibia | 5 | 2007 | 1069 | 0.070 |
Why?
|
| Cromolyn Sodium | 4 | 2001 | 78 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2010 | 562 | 0.070 |
Why?
|
| House Calls | 1 | 2009 | 161 | 0.070 |
Why?
|
| Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
| Tibial Fractures | 1 | 2010 | 272 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 829 | 0.070 |
Why?
|
| Skinfold Thickness | 3 | 2012 | 163 | 0.070 |
Why?
|
| Drug Prescriptions | 3 | 2008 | 1669 | 0.070 |
Why?
|
| Cell Extracts | 1 | 1987 | 135 | 0.070 |
Why?
|
| Potassium | 1 | 1991 | 1311 | 0.070 |
Why?
|
| Delayed-Action Preparations | 2 | 2010 | 962 | 0.070 |
Why?
|
| Sodium | 2 | 1994 | 1588 | 0.070 |
Why?
|
| Massachusetts | 12 | 2014 | 8835 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2018 | 6074 | 0.070 |
Why?
|
| Mutagenesis | 2 | 2021 | 1230 | 0.070 |
Why?
|
| Chi-Square Distribution | 5 | 2004 | 3410 | 0.070 |
Why?
|
| Tretinoin | 1 | 2010 | 519 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2010 | 1089 | 0.070 |
Why?
|
| Culture Media | 1 | 2009 | 895 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1229 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 378 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1186 | 0.070 |
Why?
|
| Forced Expiratory Flow Rates | 6 | 2017 | 75 | 0.070 |
Why?
|
| Peptidoglycan | 2 | 2006 | 248 | 0.070 |
Why?
|
| Agriculture | 2 | 2012 | 187 | 0.070 |
Why?
|
| Selection Bias | 2 | 2001 | 359 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1995 | 1551 | 0.070 |
Why?
|
| Probability | 5 | 2004 | 2475 | 0.070 |
Why?
|
| Genetic Privacy | 1 | 2007 | 59 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3708 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2006 | 345 | 0.070 |
Why?
|
| Social Class | 3 | 2005 | 1993 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2024 | 789 | 0.070 |
Why?
|
| Germ Cells | 2 | 2021 | 634 | 0.070 |
Why?
|
| Femoral Fractures | 1 | 2010 | 375 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2017 | 2481 | 0.070 |
Why?
|
| Mortality | 2 | 1995 | 2899 | 0.070 |
Why?
|
| Demography | 4 | 2017 | 1643 | 0.070 |
Why?
|
| Adult Children | 2 | 2003 | 103 | 0.070 |
Why?
|
| Adrenal Glands | 2 | 2024 | 552 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2010 | 1848 | 0.070 |
Why?
|
| Family Practice | 1 | 2009 | 507 | 0.070 |
Why?
|
| Mutation | 8 | 2023 | 30015 | 0.070 |
Why?
|
| Amino Acid Substitution | 3 | 2005 | 1739 | 0.070 |
Why?
|
| Codon, Nonsense | 1 | 2007 | 284 | 0.070 |
Why?
|
| Semantics | 1 | 1990 | 612 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2011 | 1989 | 0.070 |
Why?
|
| Anti-Allergic Agents | 1 | 2007 | 153 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1996 | 1241 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 674 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 2009 | 1085 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2009 | 748 | 0.060 |
Why?
|
| Leukemia | 1 | 2014 | 1520 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18220 | 0.060 |
Why?
|
| Ovalbumin | 2 | 2018 | 675 | 0.060 |
Why?
|
| State Health Plans | 1 | 2008 | 219 | 0.060 |
Why?
|
| Basophils | 2 | 2021 | 407 | 0.060 |
Why?
|
| Angina Pectoris | 3 | 1997 | 959 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2007 | 392 | 0.060 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1859 | 0.060 |
Why?
|
| Elastin | 2 | 2005 | 298 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1081 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2008 | 334 | 0.060 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 13 | 0.060 |
Why?
|
| Cardiomegaly | 2 | 1985 | 590 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2011 | 375 | 0.060 |
Why?
|
| Hypertriglyceridemia | 2 | 1999 | 293 | 0.060 |
Why?
|
| Glucose | 2 | 2020 | 4345 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2010 | 8165 | 0.060 |
Why?
|
| Th1 Cells | 3 | 2005 | 1027 | 0.060 |
Why?
|
| Suburban Population | 1 | 2005 | 54 | 0.060 |
Why?
|
| Interleukin-17 | 2 | 2017 | 911 | 0.060 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2021 | 330 | 0.060 |
Why?
|
| Osteoblasts | 1 | 2011 | 1141 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 1993 | 1178 | 0.060 |
Why?
|
| Toll-Like Receptors | 3 | 2004 | 575 | 0.060 |
Why?
|
| Sulfonamides | 2 | 2013 | 1977 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 2644 | 0.060 |
Why?
|
| Perception | 1 | 1992 | 1199 | 0.060 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2008 | 348 | 0.060 |
Why?
|
| Up-Regulation | 4 | 2018 | 4117 | 0.060 |
Why?
|
| Motivation | 1 | 1995 | 2003 | 0.060 |
Why?
|
| Medicaid | 3 | 2008 | 2814 | 0.060 |
Why?
|
| Organ Specificity | 3 | 2016 | 1964 | 0.060 |
Why?
|
| Homozygote | 3 | 2018 | 1776 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2007 | 1490 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2020 | 3394 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 3842 | 0.060 |
Why?
|
| Propensity Score | 3 | 2018 | 1912 | 0.060 |
Why?
|
| Heart | 2 | 2010 | 4403 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2009 | 634 | 0.060 |
Why?
|
| Least-Squares Analysis | 3 | 2017 | 368 | 0.060 |
Why?
|
| Molecular Probes | 2 | 2005 | 309 | 0.060 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2003 | 193 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2002 | 315 | 0.060 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2004 | 29 | 0.060 |
Why?
|
| Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 841 | 0.060 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 499 | 0.060 |
Why?
|
| Serpins | 1 | 2006 | 247 | 0.060 |
Why?
|
| Random Allocation | 6 | 1994 | 2392 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5305 | 0.060 |
Why?
|
| Catalytic Domain | 2 | 2005 | 704 | 0.060 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2006 | 225 | 0.060 |
Why?
|
| Quebec | 1 | 2004 | 140 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2010 | 1130 | 0.060 |
Why?
|
| Cholesterol | 6 | 2000 | 2902 | 0.060 |
Why?
|
| Medical Records | 2 | 2007 | 1408 | 0.060 |
Why?
|
| Actins | 1 | 2011 | 2051 | 0.060 |
Why?
|
| Transfection | 4 | 2002 | 5765 | 0.060 |
Why?
|
| Cost Sharing | 1 | 2008 | 409 | 0.060 |
Why?
|
| DNA Replication | 2 | 2021 | 1414 | 0.060 |
Why?
|
| Sweden | 2 | 2021 | 1379 | 0.060 |
Why?
|
| Cysteine | 1 | 2009 | 891 | 0.060 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 831 | 0.060 |
Why?
|
| Teaching | 1 | 1992 | 1169 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 1932 | 0.060 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5144 | 0.060 |
Why?
|
| Histidine | 1 | 2004 | 308 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2001 | 544 | 0.060 |
Why?
|
| Siberia | 1 | 2003 | 30 | 0.060 |
Why?
|
| Silk | 2 | 2001 | 90 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 2 | 2012 | 2465 | 0.060 |
Why?
|
| Mental Recall | 1 | 1990 | 1222 | 0.060 |
Why?
|
| Endocrine System | 1 | 2024 | 114 | 0.060 |
Why?
|
| Peptides | 4 | 2007 | 4354 | 0.060 |
Why?
|
| Fires | 2 | 1982 | 171 | 0.060 |
Why?
|
| Energy Transfer | 2 | 2001 | 108 | 0.060 |
Why?
|
| Kidney | 3 | 2016 | 7044 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 2007 | 4172 | 0.060 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1986 | 432 | 0.060 |
Why?
|
| Fracture Fixation, Internal | 1 | 2010 | 971 | 0.060 |
Why?
|
| Occupations | 1 | 1986 | 516 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2006 | 222 | 0.060 |
Why?
|
| Isoleucine | 1 | 2003 | 110 | 0.060 |
Why?
|
| DNA Probes | 1 | 2024 | 541 | 0.060 |
Why?
|
| Blood Pressure Determination | 2 | 2003 | 633 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2063 | 0.050 |
Why?
|
| Pseudomonas Infections | 1 | 2008 | 621 | 0.050 |
Why?
|
| Workflow | 2 | 2020 | 849 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 6473 | 0.050 |
Why?
|
| Rivers | 1 | 2003 | 64 | 0.050 |
Why?
|
| Tars | 1 | 1983 | 20 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2013 | 2909 | 0.050 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.050 |
Why?
|
| Tissue Distribution | 3 | 2024 | 2261 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 2 | 2001 | 167 | 0.050 |
Why?
|
| Latin America | 1 | 2024 | 407 | 0.050 |
Why?
|
| Swine | 2 | 2010 | 5908 | 0.050 |
Why?
|
| School Health Services | 1 | 1987 | 384 | 0.050 |
Why?
|
| Social Control, Formal | 1 | 1983 | 108 | 0.050 |
Why?
|
| Epidemiologic Studies | 2 | 2004 | 673 | 0.050 |
Why?
|
| Mental Status Schedule | 1 | 2003 | 315 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5863 | 0.050 |
Why?
|
| Durapatite | 1 | 2004 | 163 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2013 | 2008 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 3 | 2008 | 139 | 0.050 |
Why?
|
| Imipramine | 2 | 1993 | 98 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 361 | 0.050 |
Why?
|
| Alprazolam | 2 | 1993 | 103 | 0.050 |
Why?
|
| Biochemical Phenomena | 1 | 2003 | 58 | 0.050 |
Why?
|
| Prejudice | 1 | 2007 | 571 | 0.050 |
Why?
|
| Adenoma | 1 | 2013 | 2159 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4785 | 0.050 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2001 | 112 | 0.050 |
Why?
|
| Action Potentials | 1 | 2010 | 1825 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2022 | 25 | 0.050 |
Why?
|
| Hemochromatosis | 1 | 2004 | 174 | 0.050 |
Why?
|
| Ascariasis | 1 | 2002 | 13 | 0.050 |
Why?
|
| Ascaris lumbricoides | 1 | 2002 | 10 | 0.050 |
Why?
|
| Marijuana Abuse | 1 | 1987 | 411 | 0.050 |
Why?
|
| Government Regulation | 1 | 2007 | 524 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2013 | 2985 | 0.050 |
Why?
|
| Blood Glucose | 5 | 2005 | 6390 | 0.050 |
Why?
|
| Substance-Related Disorders | 3 | 2007 | 4416 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2013 | 6240 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 198 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2023 | 115 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1896 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2009 | 1431 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2015 | 2669 | 0.050 |
Why?
|
| Antigens, Plant | 4 | 2004 | 104 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2004 | 578 | 0.050 |
Why?
|
| Genes, Recessive | 4 | 2003 | 623 | 0.050 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2002 | 145 | 0.050 |
Why?
|
| K562 Cells | 1 | 2024 | 641 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2639 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4947 | 0.050 |
Why?
|
| Ceramides | 1 | 2023 | 200 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Anticholesteremic Agents | 2 | 2001 | 967 | 0.050 |
Why?
|
| Bone Substitutes | 1 | 2004 | 236 | 0.050 |
Why?
|
| Mouth | 2 | 2016 | 381 | 0.050 |
Why?
|
| Patient Selection | 1 | 2014 | 4237 | 0.050 |
Why?
|
| Infant Food | 1 | 2002 | 139 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2018 | 755 | 0.050 |
Why?
|
| Weight Gain | 2 | 2005 | 2349 | 0.050 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 341 | 0.050 |
Why?
|
| Adrenal Insufficiency | 1 | 2024 | 194 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 1987 | 990 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
| Temporal Arteries | 1 | 2023 | 154 | 0.050 |
Why?
|
| Health Behavior | 3 | 2014 | 2643 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 846 | 0.050 |
Why?
|
| Cell Communication | 1 | 2009 | 1654 | 0.050 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2019 | 189 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2009 | 1120 | 0.050 |
Why?
|
| Memory | 2 | 1998 | 2192 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 418 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5789 | 0.050 |
Why?
|
| Pollen | 3 | 2002 | 80 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1995 | 561 | 0.050 |
Why?
|
| Genetics | 1 | 2002 | 114 | 0.050 |
Why?
|
| Nuclear Matrix | 1 | 2001 | 30 | 0.050 |
Why?
|
| Hemodynamics | 3 | 2000 | 4160 | 0.050 |
Why?
|
| Histamine H1 Antagonists | 1 | 2002 | 100 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 5 | 2020 | 5493 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2010 | 1661 | 0.050 |
Why?
|
| Glutamine | 1 | 2004 | 576 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2008 | 4408 | 0.050 |
Why?
|
| Iceland | 1 | 2001 | 184 | 0.050 |
Why?
|
| Administration, Intranasal | 2 | 2002 | 476 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 6520 | 0.050 |
Why?
|
| Child Welfare | 2 | 2004 | 521 | 0.050 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 556 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 433 | 0.050 |
Why?
|
| Enzymes | 1 | 2003 | 257 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1692 | 0.050 |
Why?
|
| Nutrition Assessment | 1 | 2024 | 726 | 0.050 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 1980 | 94 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1667 | 0.050 |
Why?
|
| Emergency Treatment | 2 | 2008 | 495 | 0.050 |
Why?
|
| Oregon | 1 | 2001 | 147 | 0.050 |
Why?
|
| Maximal Expiratory Flow Rate | 5 | 1987 | 42 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 2015 | 3088 | 0.050 |
Why?
|
| Water Supply | 1 | 1982 | 204 | 0.050 |
Why?
|
| Social Change | 2 | 1992 | 153 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 3031 | 0.050 |
Why?
|
| Lovastatin | 1 | 2001 | 115 | 0.050 |
Why?
|
| Methionine | 1 | 2003 | 572 | 0.050 |
Why?
|
| Dyspnea | 4 | 2021 | 1347 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 40 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5672 | 0.050 |
Why?
|
| Parasitic Diseases | 1 | 2001 | 76 | 0.050 |
Why?
|
| Spiro Compounds | 1 | 2001 | 68 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 611 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2014 | 3743 | 0.050 |
Why?
|
| Genetic Research | 1 | 2021 | 171 | 0.040 |
Why?
|
| Personality | 2 | 2002 | 553 | 0.040 |
Why?
|
| Students | 1 | 1991 | 1736 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2021 | 107 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2021 | 186 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6403 | 0.040 |
Why?
|
| Helminthiasis, Animal | 1 | 2000 | 4 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2005 | 1866 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 302 | 0.040 |
Why?
|
| Hyperventilation | 3 | 1986 | 78 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 455 | 0.040 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1999 | 40 | 0.040 |
Why?
|
| Fluorine Radioisotopes | 2 | 1994 | 418 | 0.040 |
Why?
|
| Sulfotransferases | 1 | 2021 | 150 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2000 | 311 | 0.040 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2020 | 144 | 0.040 |
Why?
|
| Dysostoses | 1 | 1999 | 7 | 0.040 |
Why?
|
| Biopolymers | 1 | 2001 | 183 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 96 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2021 | 265 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 4172 | 0.040 |
Why?
|
| Cholagogues and Choleretics | 1 | 1999 | 39 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1998 | 781 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 1250 | 0.040 |
Why?
|
| Sickness Impact Profile | 1 | 2001 | 299 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2015 | 269 | 0.040 |
Why?
|
| Poverty | 4 | 2006 | 2692 | 0.040 |
Why?
|
| Lymphocyte Activation | 7 | 2006 | 5463 | 0.040 |
Why?
|
| Functional Residual Capacity | 4 | 2010 | 70 | 0.040 |
Why?
|
| Mental Health | 1 | 2014 | 3253 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2011 | 2045 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 295 | 0.040 |
Why?
|
| Motor Activity | 2 | 2010 | 2714 | 0.040 |
Why?
|
| Critical Care | 2 | 2022 | 2691 | 0.040 |
Why?
|
| Germany | 2 | 2014 | 872 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2024 | 648 | 0.040 |
Why?
|
| Panic Disorder | 2 | 1993 | 613 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 197 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 770 | 0.040 |
Why?
|
| Bronchography | 1 | 1999 | 75 | 0.040 |
Why?
|
| Isoproterenol | 3 | 2008 | 397 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2164 | 0.040 |
Why?
|
| Ketorolac | 1 | 1999 | 94 | 0.040 |
Why?
|
| Syndrome | 2 | 2004 | 3268 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 825 | 0.040 |
Why?
|
| Trisaccharides | 1 | 1998 | 50 | 0.040 |
Why?
|
| Trachea | 2 | 1999 | 1089 | 0.040 |
Why?
|
| Diffusion | 1 | 2001 | 814 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 103 | 0.040 |
Why?
|
| Neonatal Screening | 1 | 2003 | 597 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2020 | 2851 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11069 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3222 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 1987 | 1188 | 0.040 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1999 | 131 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 244 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2009 | 2881 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1998 | 1797 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 470 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 647 | 0.040 |
Why?
|
| Cathepsins | 1 | 1999 | 241 | 0.040 |
Why?
|
| Colestipol | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 1999 | 1528 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2011 | 1701 | 0.040 |
Why?
|
| Minority Groups | 2 | 2022 | 1202 | 0.040 |
Why?
|
| Nails | 1 | 2020 | 296 | 0.040 |
Why?
|
| Ileum | 1 | 2021 | 557 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 100 | 0.040 |
Why?
|
| Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
| Africa | 1 | 2020 | 714 | 0.040 |
Why?
|
| Pharmacokinetics | 2 | 2010 | 86 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 344 | 0.040 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 1999 | 114 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2001 | 432 | 0.040 |
Why?
|
| Terbutaline | 1 | 1997 | 23 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2021 | 364 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Milk, Human | 1 | 2022 | 486 | 0.040 |
Why?
|
| Drug Therapy, Combination | 6 | 2011 | 6305 | 0.040 |
Why?
|
| Personality Disorders | 1 | 2003 | 723 | 0.040 |
Why?
|
| Thinness | 1 | 2001 | 480 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2020 | 488 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2018 | 96 | 0.040 |
Why?
|
| Adiposity | 1 | 2008 | 1879 | 0.040 |
Why?
|
| Bacteroides | 1 | 2018 | 165 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2004 | 1470 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 831 | 0.040 |
Why?
|
| Cost of Illness | 3 | 2002 | 1937 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2004 | 825 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2009 | 3095 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1131 | 0.040 |
Why?
|
| Epidemiology | 1 | 1980 | 279 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 1998 | 2413 | 0.040 |
Why?
|
| Thorax | 1 | 1981 | 555 | 0.040 |
Why?
|
| Ciliary Body | 1 | 1998 | 167 | 0.040 |
Why?
|
| Pravastatin | 1 | 2000 | 392 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 474 | 0.040 |
Why?
|
| Fungi | 1 | 2020 | 338 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 362 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2002 | 761 | 0.040 |
Why?
|
| Phosphorylases | 1 | 1997 | 17 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 1443 | 0.040 |
Why?
|
| Epigenomics | 1 | 2023 | 942 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2001 | 396 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2015 | 866 | 0.040 |
Why?
|
| Glycogen Storage Disease Type V | 1 | 1997 | 8 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1074 | 0.040 |
Why?
|
| Brain | 4 | 2020 | 27100 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1999 | 704 | 0.040 |
Why?
|
| Meglumine | 1 | 2018 | 143 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2010 | 2279 | 0.040 |
Why?
|
| Pulmonary Ventilation | 5 | 1994 | 372 | 0.040 |
Why?
|
| Plant Roots | 1 | 2017 | 117 | 0.040 |
Why?
|
| Anterior Eye Segment | 1 | 1998 | 143 | 0.040 |
Why?
|
| Soil Microbiology | 1 | 2017 | 88 | 0.040 |
Why?
|
| Zea mays | 1 | 2017 | 110 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 1999 | 250 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2020 | 837 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
|
| Simvastatin | 1 | 2000 | 346 | 0.040 |
Why?
|
| Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.040 |
Why?
|
| Pregnancy Outcome | 2 | 2014 | 2921 | 0.040 |
Why?
|
| Abdomen | 2 | 1994 | 1128 | 0.040 |
Why?
|
| Bone Remodeling | 1 | 2001 | 581 | 0.040 |
Why?
|
| Neoplasms | 4 | 2020 | 22131 | 0.040 |
Why?
|
| Desmosine | 1 | 1996 | 19 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1997 | 317 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1997 | 201 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.040 |
Why?
|
| Niacin | 1 | 1998 | 118 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 1997 | 113 | 0.030 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 1998 | 93 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1340 | 0.030 |
Why?
|
| Infant Formula | 1 | 2018 | 194 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2008 | 2328 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 158 | 0.030 |
Why?
|
| Mice, Transgenic | 4 | 2024 | 9526 | 0.030 |
Why?
|
| Protein Folding | 1 | 2001 | 870 | 0.030 |
Why?
|
| Radiopharmaceuticals | 2 | 1999 | 2650 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1999 | 685 | 0.030 |
Why?
|
| Amino Acids | 1 | 2023 | 1718 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9715 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2008 | 1846 | 0.030 |
Why?
|
| Clonal Deletion | 1 | 1996 | 74 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 250 | 0.030 |
Why?
|
| Protease Nexins | 2 | 2006 | 39 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2012 | 813 | 0.030 |
Why?
|
| NAD | 1 | 2020 | 614 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2008 | 1937 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 384 | 0.030 |
Why?
|
| Oocytes | 1 | 2021 | 1166 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2023 | 2570 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2003 | 1397 | 0.030 |
Why?
|
| Testis | 1 | 2000 | 792 | 0.030 |
Why?
|
| Cations | 1 | 1997 | 238 | 0.030 |
Why?
|
| Ferritins | 1 | 2019 | 597 | 0.030 |
Why?
|
| Indoles | 2 | 2002 | 1830 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 2009 | 3735 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2000 | 638 | 0.030 |
Why?
|
| Dopamine | 2 | 1994 | 1606 | 0.030 |
Why?
|
| Radiography, Thoracic | 2 | 2000 | 1302 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2004 | 1683 | 0.030 |
Why?
|
| Energy Intake | 3 | 1992 | 2133 | 0.030 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2008 | 323 | 0.030 |
Why?
|
| Heptanoic Acids | 1 | 1998 | 344 | 0.030 |
Why?
|
| Gastrectomy | 1 | 2021 | 671 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.030 |
Why?
|
| Myocardial Infarction | 6 | 1997 | 11458 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 6126 | 0.030 |
Why?
|
| Irritants | 1 | 1995 | 43 | 0.030 |
Why?
|
| Self Tolerance | 1 | 1996 | 123 | 0.030 |
Why?
|
| Amines | 1 | 2017 | 281 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 69 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 747 | 0.030 |
Why?
|
| Ascorbic Acid Deficiency | 2 | 1998 | 25 | 0.030 |
Why?
|
| Pseudogenes | 1 | 1995 | 104 | 0.030 |
Why?
|
| Residence Characteristics | 3 | 2001 | 2092 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 26 | 0.030 |
Why?
|
| Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 286 | 0.030 |
Why?
|
| Sialic Acids | 1 | 1995 | 123 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| Collagen | 3 | 2001 | 2634 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2020 | 701 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2000 | 907 | 0.030 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 485 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2024 | 2298 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1146 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 340 | 0.030 |
Why?
|
| Acute Disease | 7 | 2006 | 7236 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 901 | 0.030 |
Why?
|
| Carboxyhemoglobin | 3 | 1992 | 83 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 624 | 0.030 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 1995 | 10 | 0.030 |
Why?
|
| Magnetoencephalography | 1 | 1999 | 636 | 0.030 |
Why?
|
| Radiometry | 1 | 2001 | 812 | 0.030 |
Why?
|
| Uveal Neoplasms | 1 | 1998 | 341 | 0.030 |
Why?
|
| Health Status | 1 | 2008 | 4076 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2002 | 821 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2017 | 233 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 730 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9277 | 0.030 |
Why?
|
| Mitogens | 2 | 2005 | 229 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2009 | 3196 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 1007 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2006 | 3998 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 2 | 1998 | 928 | 0.030 |
Why?
|
| Peer Group | 2 | 2005 | 692 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1995 | 174 | 0.030 |
Why?
|
| Apoptosis | 2 | 2009 | 9476 | 0.030 |
Why?
|
| Mexico | 2 | 2009 | 757 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2011 | 277 | 0.030 |
Why?
|
| Neurons | 3 | 2000 | 9436 | 0.030 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 322 | 0.030 |
Why?
|
| Hearing Disorders | 1 | 1975 | 126 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1995 | 310 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 1483 | 0.030 |
Why?
|
| Inspiratory Capacity | 4 | 1999 | 35 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2000 | 707 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 351 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2018 | 823 | 0.030 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1996 | 242 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2023 | 3419 | 0.030 |
Why?
|
| Depression | 2 | 2022 | 8132 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1998 | 2546 | 0.030 |
Why?
|
| Y Chromosome | 1 | 1995 | 205 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2231 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1995 | 243 | 0.030 |
Why?
|
| Endosomes | 1 | 1997 | 522 | 0.030 |
Why?
|
| Magnesium Deficiency | 1 | 1994 | 48 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2006 | 3183 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 646 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2020 | 1503 | 0.030 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2014 | 63 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2222 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2004 | 1865 | 0.030 |
Why?
|
| Papaverine | 1 | 1973 | 45 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
| Cell Lineage | 2 | 2000 | 2553 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2015 | 194 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2000 | 1670 | 0.030 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1996 | 290 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2004 | 2977 | 0.030 |
Why?
|
| Cytosol | 1 | 1997 | 886 | 0.030 |
Why?
|
| Program Development | 1 | 2000 | 1293 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2017 | 400 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 583 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1336 | 0.030 |
Why?
|
| Thymus Gland | 2 | 1998 | 1243 | 0.030 |
Why?
|
| Spouses | 1 | 1996 | 283 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13635 | 0.030 |
Why?
|
| Taste | 1 | 1995 | 189 | 0.030 |
Why?
|
| Camptothecin | 1 | 2017 | 591 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2013 | 38 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6927 | 0.030 |
Why?
|
| Radiography | 2 | 2000 | 6961 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8998 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 407 | 0.030 |
Why?
|
| Social Identification | 1 | 1994 | 108 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5034 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1994 | 333 | 0.030 |
Why?
|
| Cognition | 2 | 2003 | 6988 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 1996 | 529 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 436 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 1998 | 2234 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3979 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1756 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2006 | 3442 | 0.030 |
Why?
|
| Viruses | 1 | 2017 | 374 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 1995 | 404 | 0.030 |
Why?
|
| Meningitis | 1 | 1995 | 217 | 0.030 |
Why?
|
| Cysts | 1 | 1998 | 680 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3205 | 0.030 |
Why?
|
| Gout | 1 | 2000 | 621 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 1997 | 988 | 0.030 |
Why?
|
| Health Services Accessibility | 2 | 2008 | 5430 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2088 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2021 | 2486 | 0.030 |
Why?
|
| Antigens, Bacterial | 1 | 1998 | 1141 | 0.030 |
Why?
|
| Smell | 1 | 1995 | 259 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2012 | 90 | 0.030 |
Why?
|
| Gadolinium | 1 | 2018 | 959 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 799 | 0.030 |
Why?
|
| Survival Rate | 2 | 2006 | 12719 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2018 | 858 | 0.030 |
Why?
|
| Models, Animal | 2 | 2012 | 2108 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2012 | 231 | 0.030 |
Why?
|
| Death, Sudden | 1 | 1994 | 301 | 0.030 |
Why?
|
| Nutrition Surveys | 2 | 2005 | 1725 | 0.030 |
Why?
|
| Alcoholic Beverages | 1 | 1994 | 264 | 0.030 |
Why?
|
| SRS-A | 1 | 1992 | 132 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 584 | 0.030 |
Why?
|
| Pyrenes | 1 | 2012 | 49 | 0.030 |
Why?
|
| Xanthines | 1 | 1992 | 120 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 2012 | 74 | 0.030 |
Why?
|
| Cell Division | 1 | 2000 | 4457 | 0.030 |
Why?
|
| Fetal Organ Maturity | 1 | 1992 | 83 | 0.030 |
Why?
|
| Untranslated Regions | 1 | 2012 | 29 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 2409 | 0.030 |
Why?
|
| Sarcosine Dehydrogenase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 2011 | 5 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2012 | 452 | 0.030 |
Why?
|
| Sp3 Transcription Factor | 1 | 2011 | 27 | 0.030 |
Why?
|
| Matched-Pair Analysis | 2 | 2004 | 284 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1864 | 0.030 |
Why?
|
| Pregnancy, Multiple | 1 | 1993 | 215 | 0.030 |
Why?
|
| Aminohydrolases | 1 | 2011 | 18 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 631 | 0.020 |
Why?
|
| Equipment Design | 1 | 2000 | 3501 | 0.020 |
Why?
|
| RNA Interference | 1 | 2020 | 2829 | 0.020 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 17 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1993 | 137 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2090 | 0.020 |
Why?
|
| Prostatic Hyperplasia | 1 | 1996 | 521 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 36401 | 0.020 |
Why?
|
| Physical Exertion | 2 | 1993 | 668 | 0.020 |
Why?
|
| X Chromosome | 1 | 1995 | 816 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2015 | 803 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 733 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 1995 | 733 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 1998 | 991 | 0.020 |
Why?
|
| Point Mutation | 1 | 1997 | 1595 | 0.020 |
Why?
|
| Diarrhea | 1 | 2018 | 1317 | 0.020 |
Why?
|
| France | 1 | 2013 | 492 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 244 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 933 | 0.020 |
Why?
|
| Water | 2 | 1998 | 1409 | 0.020 |
Why?
|
| Pyrroles | 1 | 1998 | 1125 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 737 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2445 | 0.020 |
Why?
|
| Binding Sites | 2 | 2010 | 6051 | 0.020 |
Why?
|
| Fluconazole | 1 | 1992 | 157 | 0.020 |
Why?
|
| Hip | 1 | 1992 | 255 | 0.020 |
Why?
|
| Alu Elements | 1 | 2011 | 115 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 292 | 0.020 |
Why?
|
| Interleukins | 2 | 2008 | 783 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1991 | 46 | 0.020 |
Why?
|
| Diabetic Neuropathies | 1 | 1975 | 405 | 0.020 |
Why?
|
| Personality Inventory | 1 | 1994 | 1018 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 1995 | 978 | 0.020 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 1991 | 20 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 8516 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3447 | 0.020 |
Why?
|
| Fractures, Malunited | 1 | 2011 | 82 | 0.020 |
Why?
|
| Community Networks | 1 | 2013 | 201 | 0.020 |
Why?
|
| Gene Library | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 615 | 0.020 |
Why?
|
| Caribbean Region | 1 | 2011 | 192 | 0.020 |
Why?
|
| Tubulin | 1 | 1994 | 692 | 0.020 |
Why?
|
| Encephalitis | 1 | 1995 | 438 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2000 | 2419 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2001 | 20988 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 1994 | 425 | 0.020 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2010 | 56 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1998 | 1505 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2000 | 1604 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2001 | 2218 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 667 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 416 | 0.020 |
Why?
|
| Paired-Associate Learning | 1 | 1990 | 54 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1999 | 1248 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1991 | 291 | 0.020 |
Why?
|
| Vitamin B 6 | 1 | 2011 | 234 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 1992 | 405 | 0.020 |
Why?
|
| Pandemics | 2 | 2021 | 8652 | 0.020 |
Why?
|
| Pulmonary Medicine | 2 | 2006 | 221 | 0.020 |
Why?
|
| Veterans | 2 | 2003 | 2649 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1836 | 0.020 |
Why?
|
| Body Burden | 2 | 2004 | 158 | 0.020 |
Why?
|
| Retinitis Pigmentosa | 1 | 1994 | 397 | 0.020 |
Why?
|
| Heart Block | 2 | 1998 | 384 | 0.020 |
Why?
|
| Markov Chains | 2 | 2006 | 965 | 0.020 |
Why?
|
| Immunity | 1 | 2016 | 994 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 808 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 348 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1992 | 379 | 0.020 |
Why?
|
| Barbados | 1 | 2009 | 52 | 0.020 |
Why?
|
| Intradermal Tests | 2 | 2001 | 42 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 1992 | 378 | 0.020 |
Why?
|
| Weight Loss | 1 | 2001 | 2682 | 0.020 |
Why?
|
| New England | 2 | 2005 | 1050 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 1526 | 0.020 |
Why?
|
| Self Care | 2 | 2006 | 796 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 3680 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 899 | 0.020 |
Why?
|
| Inhalation | 1 | 2010 | 143 | 0.020 |
Why?
|
| Societies, Medical | 2 | 2018 | 3901 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2006 | 702 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1896 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2009 | 106 | 0.020 |
Why?
|
| Anesthesia | 1 | 2000 | 1591 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 253 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2009 | 162 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2011 | 343 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 852 | 0.020 |
Why?
|
| Data Compression | 1 | 2009 | 70 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 319 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 1994 | 796 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2010 | 294 | 0.020 |
Why?
|
| Morals | 1 | 1992 | 289 | 0.020 |
Why?
|
| Anxiety Disorders | 2 | 1998 | 2724 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2315 | 0.020 |
Why?
|
| Mitomycins | 1 | 1988 | 46 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 767 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2202 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 3415 | 0.020 |
Why?
|
| Carbon | 1 | 2012 | 665 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1991 | 586 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 456 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 1989 | 236 | 0.020 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1993 | 512 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2009 | 613 | 0.020 |
Why?
|
| Autoimmunity | 1 | 1996 | 1350 | 0.020 |
Why?
|
| Echocardiography | 1 | 2021 | 4987 | 0.020 |
Why?
|
| Pregnenediones | 1 | 1988 | 29 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 666 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 1993 | 831 | 0.020 |
Why?
|
| Hemoglobins | 3 | 2010 | 1524 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 2 | 2001 | 143 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 2561 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 4512 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1996 | 1985 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5239 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2011 | 597 | 0.020 |
Why?
|
| Coffee | 1 | 1992 | 592 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2008 | 107 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 317 | 0.020 |
Why?
|
| Research | 1 | 2016 | 1977 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2009 | 277 | 0.020 |
Why?
|
| Seasons | 1 | 1993 | 1518 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1997 | 3680 | 0.020 |
Why?
|
| Viral Load | 1 | 2017 | 3325 | 0.020 |
Why?
|
| Twins | 1 | 1989 | 340 | 0.020 |
Why?
|
| Frail Elderly | 1 | 1993 | 765 | 0.020 |
Why?
|
| Bone Plates | 1 | 2010 | 464 | 0.020 |
Why?
|
| Mitomycin | 1 | 1988 | 263 | 0.020 |
Why?
|
| Registries | 2 | 2020 | 8209 | 0.020 |
Why?
|
| Health | 1 | 2010 | 398 | 0.020 |
Why?
|
| Collagen Type I | 2 | 2001 | 616 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 11735 | 0.020 |
Why?
|
| Models, Econometric | 1 | 2008 | 215 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 1989 | 470 | 0.020 |
Why?
|
| Dietary Fiber | 1 | 1991 | 758 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2000 | 3238 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1997 | 1813 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4269 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6763 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2006 | 1723 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2000 | 10072 | 0.020 |
Why?
|
| Complement C5 | 2 | 1997 | 103 | 0.020 |
Why?
|
| Vinblastine | 1 | 1988 | 488 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2010 | 298 | 0.020 |
Why?
|
| Informatics | 1 | 2007 | 72 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6418 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 1150 | 0.020 |
Why?
|
| Heart Conduction System | 2 | 1998 | 992 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 99 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2013 | 1493 | 0.020 |
Why?
|
| Postpartum Period | 1 | 1993 | 1178 | 0.020 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 39 | 0.020 |
Why?
|
| Crosses, Genetic | 2 | 1998 | 750 | 0.020 |
Why?
|
| Hydralazine | 1 | 1986 | 34 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 602 | 0.020 |
Why?
|
| Diet Surveys | 1 | 1990 | 1161 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 355 | 0.020 |
Why?
|
| Residual Volume | 2 | 1988 | 41 | 0.020 |
Why?
|
| Zinc | 1 | 1990 | 687 | 0.020 |
Why?
|
| Australia | 1 | 2009 | 1249 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 615 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 2048 | 0.020 |
Why?
|
| Tropoelastin | 1 | 2005 | 28 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2012 | 1460 | 0.020 |
Why?
|
| Insurance | 1 | 2007 | 113 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
| RNA Stability | 1 | 2007 | 320 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 1525 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2017 | 4210 | 0.020 |
Why?
|
| Polysorbates | 1 | 2005 | 44 | 0.020 |
Why?
|
| Minnesota | 1 | 1986 | 338 | 0.020 |
Why?
|
| Brain Death | 1 | 2008 | 357 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 43 | 0.020 |
Why?
|
| Croup | 1 | 1985 | 23 | 0.020 |
Why?
|
| Clinical Medicine | 1 | 2006 | 145 | 0.020 |
Why?
|
| Administration, Topical | 2 | 2003 | 703 | 0.020 |
Why?
|
| Lung Neoplasms | 3 | 1987 | 13383 | 0.020 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 160 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2456 | 0.020 |
Why?
|
| Michigan | 1 | 1986 | 339 | 0.020 |
Why?
|
| Pain | 1 | 2000 | 5062 | 0.020 |
Why?
|
| Quality of Health Care | 2 | 2003 | 4325 | 0.020 |
Why?
|
| Allergy and Immunology | 1 | 2006 | 176 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2006 | 198 | 0.020 |
Why?
|
| Counseling | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Metered Dose Inhalers | 1 | 2004 | 25 | 0.020 |
Why?
|
| Accidental Falls | 1 | 1993 | 1067 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2005 | 137 | 0.010 |
Why?
|
| Puberty | 1 | 2008 | 501 | 0.010 |
Why?
|
| Lipid A | 1 | 2004 | 70 | 0.010 |
Why?
|
| Desipramine | 1 | 2004 | 182 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 167 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 2004 | 165 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 1780 | 0.010 |
Why?
|
| Protein Binding | 1 | 2017 | 9345 | 0.010 |
Why?
|
| Connecticut | 1 | 2005 | 364 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3037 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1997 | 410 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2008 | 429 | 0.010 |
Why?
|
| Epoxide Hydrolases | 1 | 2005 | 122 | 0.010 |
Why?
|
| Eating | 1 | 1991 | 1535 | 0.010 |
Why?
|
| Income | 3 | 2000 | 1870 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 310 | 0.010 |
Why?
|
| Endocytosis | 1 | 2008 | 955 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1984 | 83 | 0.010 |
Why?
|
| Microtubules | 1 | 2009 | 1073 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 195 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 2005 | 265 | 0.010 |
Why?
|
| Reaction Time | 1 | 1990 | 2087 | 0.010 |
Why?
|
| Diagnosis | 1 | 1964 | 156 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1812 | 0.010 |
Why?
|
| YY1 Transcription Factor | 1 | 2003 | 60 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 581 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 1921 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2015 | 2602 | 0.010 |
Why?
|
| Sinusitis | 1 | 1992 | 991 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1990 | 1835 | 0.010 |
Why?
|
| Apolipoprotein E3 | 1 | 2003 | 107 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2006 | 908 | 0.010 |
Why?
|
| Infant Equipment | 1 | 2002 | 23 | 0.010 |
Why?
|
| Animals, Domestic | 1 | 2002 | 56 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 783 | 0.010 |
Why?
|
| Apolipoprotein E2 | 1 | 2003 | 135 | 0.010 |
Why?
|
| Rheumatoid Nodule | 1 | 1982 | 15 | 0.010 |
Why?
|
| Myocardium | 1 | 2016 | 4725 | 0.010 |
Why?
|
| Public Policy | 1 | 1987 | 557 | 0.010 |
Why?
|
| Osseointegration | 1 | 2004 | 274 | 0.010 |
Why?
|
| Urban Health | 1 | 2005 | 532 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13442 | 0.010 |
Why?
|
| Flucytosine | 1 | 1982 | 33 | 0.010 |
Why?
|
| Fistula | 1 | 1984 | 212 | 0.010 |
Why?
|
| Neurotoxins | 1 | 2003 | 240 | 0.010 |
Why?
|
| Selenium | 1 | 2005 | 417 | 0.010 |
Why?
|
| Phenylcarbamates | 1 | 2002 | 38 | 0.010 |
Why?
|
| Skin | 1 | 2016 | 4472 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1993 | 1914 | 0.010 |
Why?
|
| Lung Abscess | 1 | 1982 | 40 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 332 | 0.010 |
Why?
|
| Neuropsychological Tests | 2 | 1998 | 7050 | 0.010 |
Why?
|
| Macrophages | 1 | 1997 | 5758 | 0.010 |
Why?
|
| Alternaria | 1 | 2002 | 42 | 0.010 |
Why?
|
| Hematocrit | 1 | 1983 | 623 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1988 | 1436 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1982 | 142 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2002 | 115 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2004 | 254 | 0.010 |
Why?
|
| Aphakia, Postcataract | 1 | 1982 | 52 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 1901 | 0.010 |
Why?
|
| Isotope Labeling | 2 | 1994 | 392 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2007 | 6016 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3798 | 0.010 |
Why?
|
| Organizational Innovation | 1 | 2004 | 537 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1991 | 3392 | 0.010 |
Why?
|
| Vision Tests | 1 | 1982 | 161 | 0.010 |
Why?
|
| Cytosine | 1 | 1982 | 211 | 0.010 |
Why?
|
| Particle Size | 1 | 2005 | 1648 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2697 | 0.010 |
Why?
|
| Fluoxetine | 1 | 2004 | 733 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1503 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2009 | 3752 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1575 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 2518 | 0.010 |
Why?
|
| Materials Testing | 1 | 2004 | 863 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 840 | 0.010 |
Why?
|
| Employment | 1 | 2007 | 1113 | 0.010 |
Why?
|
| Health Services | 1 | 2005 | 751 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 12966 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 1687 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2001 | 274 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 512 | 0.010 |
Why?
|
| Total Lung Capacity | 1 | 1980 | 149 | 0.010 |
Why?
|
| Norway | 1 | 2001 | 499 | 0.010 |
Why?
|
| Antigens | 1 | 2006 | 1441 | 0.010 |
Why?
|
| Recreation | 1 | 2001 | 125 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1993 | 2492 | 0.010 |
Why?
|
| Family Characteristics | 1 | 2005 | 992 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 2 | 1994 | 1122 | 0.010 |
Why?
|
| Cathepsin K | 1 | 1999 | 63 | 0.010 |
Why?
|
| Melanoma | 1 | 1998 | 5696 | 0.010 |
Why?
|
| Naloxone | 1 | 1982 | 370 | 0.010 |
Why?
|
| Attention | 1 | 1990 | 2396 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3841 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2000 | 239 | 0.010 |
Why?
|
| Candidiasis | 1 | 1982 | 365 | 0.010 |
Why?
|
| Micrognathism | 1 | 1999 | 63 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2003 | 733 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1988 | 917 | 0.010 |
Why?
|
| Acarbose | 1 | 1998 | 10 | 0.010 |
Why?
|
| Testosterone | 2 | 2000 | 2472 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1995 | 2509 | 0.010 |
Why?
|
| Therapeutic Equivalency | 1 | 1999 | 134 | 0.010 |
Why?
|
| Adipocytes | 1 | 2006 | 1187 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1999 | 110 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 970 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 283 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2008 | 2329 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2003 | 709 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2756 | 0.010 |
Why?
|
| Vehicle Emissions | 1 | 1983 | 655 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2000 | 258 | 0.010 |
Why?
|
| Helium | 2 | 1990 | 119 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 1329 | 0.010 |
Why?
|
| Growth | 1 | 2000 | 365 | 0.010 |
Why?
|
| Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
| Aerosols | 2 | 1993 | 635 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2079 | 0.010 |
Why?
|
| Spleen | 1 | 2004 | 2286 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1981 | 323 | 0.010 |
Why?
|
| Sulfur Dioxide | 1 | 1998 | 178 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1998 | 317 | 0.010 |
Why?
|
| Leptin | 1 | 2006 | 1595 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16968 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1997 | 72 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2000 | 333 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2004 | 1355 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2006 | 988 | 0.010 |
Why?
|
| Surface Properties | 1 | 1980 | 1162 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 245 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2004 | 1270 | 0.010 |
Why?
|
| Vocabulary | 1 | 1998 | 166 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8311 | 0.010 |
Why?
|
| Otitis Media | 1 | 1999 | 286 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1980 | 773 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1998 | 659 | 0.010 |
Why?
|
| Postprandial Period | 1 | 1998 | 314 | 0.010 |
Why?
|
| Phosphates | 1 | 2000 | 769 | 0.010 |
Why?
|
| Urea | 1 | 1999 | 443 | 0.010 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 1997 | 102 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1662 | 0.010 |
Why?
|
| Social Conditions | 1 | 1997 | 120 | 0.010 |
Why?
|
| Health Services Research | 1 | 2004 | 1808 | 0.010 |
Why?
|
| Spectrophotometry, Atomic | 1 | 1996 | 82 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1980 | 505 | 0.010 |
Why?
|
| Body Temperature | 1 | 1999 | 780 | 0.010 |
Why?
|
| Decision Making | 1 | 1990 | 3919 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 794 | 0.010 |
Why?
|
| Receptors, Interleukin-9 | 1 | 1995 | 4 | 0.010 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1995 | 20 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2001 | 642 | 0.010 |
Why?
|
| Prednisone | 1 | 2000 | 1562 | 0.010 |
Why?
|
| Cataract | 1 | 1982 | 832 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2000 | 629 | 0.010 |
Why?
|
| Life Change Events | 1 | 2001 | 953 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8603 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1984 | 1927 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 1982 | 1987 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 1995 | 141 | 0.010 |
Why?
|
| Hair Cells, Auditory | 1 | 1998 | 381 | 0.010 |
Why?
|
| Photons | 1 | 1999 | 589 | 0.010 |
Why?
|
| Chronobiology Phenomena | 1 | 1995 | 29 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 422 | 0.010 |
Why?
|
| Retirement | 1 | 1996 | 197 | 0.010 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1975 | 115 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1995 | 143 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 2746 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 1229 | 0.010 |
Why?
|
| Middle East | 1 | 1995 | 231 | 0.010 |
Why?
|
| Albuminuria | 1 | 1998 | 655 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 777 | 0.010 |
Why?
|
| Giant Cells | 1 | 1995 | 188 | 0.010 |
Why?
|
| Audiometry | 1 | 1975 | 252 | 0.010 |
Why?
|
| Life Style | 1 | 2006 | 3907 | 0.010 |
Why?
|
| Social Behavior | 1 | 2001 | 1135 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 343 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 1998 | 466 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1973 | 117 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1973 | 245 | 0.010 |
Why?
|
| Pulse | 1 | 1973 | 217 | 0.010 |
Why?
|
| Spinal Fractures | 1 | 2000 | 704 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1997 | 963 | 0.010 |
Why?
|
| Rodentia | 1 | 1995 | 261 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11107 | 0.010 |
Why?
|
| Estradiol | 1 | 2000 | 1937 | 0.010 |
Why?
|
| New York City | 1 | 1995 | 731 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1995 | 601 | 0.010 |
Why?
|
| Remission Induction | 1 | 1999 | 2391 | 0.010 |
Why?
|
| Bacterial Typing Techniques | 1 | 1993 | 263 | 0.010 |
Why?
|
| Switzerland | 1 | 1993 | 318 | 0.010 |
Why?
|
| Speech | 1 | 1998 | 555 | 0.010 |
Why?
|
| Agoraphobia | 1 | 1993 | 177 | 0.010 |
Why?
|
| Neuroimmunomodulation | 1 | 1995 | 184 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 1994 | 244 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1973 | 379 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2004 | 2896 | 0.010 |
Why?
|
| Vitamin A | 1 | 1995 | 612 | 0.010 |
Why?
|
| Consanguinity | 1 | 1994 | 456 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 2241 | 0.010 |
Why?
|
| Pattern Recognition, Visual | 1 | 1998 | 824 | 0.010 |
Why?
|
| Morbidity | 1 | 1997 | 1750 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1973 | 1376 | 0.010 |
Why?
|
| Adenine | 1 | 1997 | 985 | 0.010 |
Why?
|
| Curriculum | 1 | 1985 | 3739 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2001 | 1999 | 0.010 |
Why?
|
| Brachytherapy | 1 | 1998 | 1223 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 1993 | 410 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1743 | 0.010 |
Why?
|
| Nurses | 1 | 1999 | 2477 | 0.010 |
Why?
|
| Developing Countries | 1 | 2002 | 2868 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 3683 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 1882 | 0.010 |
Why?
|
| Medically Uninsured | 1 | 1995 | 835 | 0.010 |
Why?
|
| Neuroglia | 1 | 1994 | 954 | 0.000 |
Why?
|
| Seroepidemiologic Studies | 1 | 1990 | 398 | 0.000 |
Why?
|
| DNA, Bacterial | 1 | 1993 | 1471 | 0.000 |
Why?
|
| Education, Medical | 1 | 1980 | 1725 | 0.000 |
Why?
|
| Maximal Expiratory Flow-Volume Curves | 1 | 1987 | 25 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1975 | 1315 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1993 | 625 | 0.000 |
Why?
|
| Arizona | 1 | 1987 | 107 | 0.000 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 182 | 0.000 |
Why?
|
| Dietary Carbohydrates | 1 | 1992 | 891 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1994 | 2328 | 0.000 |
Why?
|
| Methods | 1 | 1987 | 1065 | 0.000 |
Why?
|
| Dietary Proteins | 1 | 1992 | 951 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1998 | 2478 | 0.000 |
Why?
|
| Sleep | 1 | 2002 | 4764 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1999 | 8619 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1986 | 142 | 0.000 |
Why?
|
| Atrial Fibrillation | 1 | 1964 | 5031 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1986 | 455 | 0.000 |
Why?
|
| Rabbits | 1 | 1992 | 4770 | 0.000 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1994 | 2008 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1996 | 4910 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1998 | 5965 | 0.000 |
Why?
|
| Hybridomas | 1 | 1986 | 442 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1986 | 464 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1965 | 400 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1301 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1999 | 6635 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11118 | 0.000 |
Why?
|
| Brugada Syndrome | 1 | 1964 | 91 | 0.000 |
Why?
|
| Endorphins | 1 | 1982 | 74 | 0.000 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 1982 | 87 | 0.000 |
Why?
|
| Insurance, Health | 1 | 1995 | 2495 | 0.000 |
Why?
|
| Oxygen | 2 | 1987 | 4226 | 0.000 |
Why?
|
| Clone Cells | 1 | 1986 | 1657 | 0.000 |
Why?
|
| Physicians | 1 | 1980 | 4583 | 0.000 |
Why?
|
| Premedication | 1 | 1982 | 245 | 0.000 |
Why?
|
| Exercise Test | 1 | 1989 | 2127 | 0.000 |
Why?
|
| Health Promotion | 1 | 1993 | 2206 | 0.000 |
Why?
|
| Pharyngitis | 1 | 1982 | 220 | 0.000 |
Why?
|
| Eyeglasses | 1 | 1982 | 138 | 0.000 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 1980 | 20 | 0.000 |
Why?
|
| Lenses, Intraocular | 1 | 1982 | 139 | 0.000 |
Why?
|
| Hair | 1 | 1983 | 498 | 0.000 |
Why?
|
| Nucleotides, Cyclic | 1 | 1980 | 84 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1980 | 398 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1986 | 1779 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2000 | 20556 | 0.000 |
Why?
|
| Exercise | 1 | 1993 | 5886 | 0.000 |
Why?
|
| Progesterone | 1 | 1980 | 742 | 0.000 |
Why?
|
| Sarcoidosis | 1 | 1980 | 520 | 0.000 |
Why?
|
| Estrogens | 1 | 1980 | 1521 | 0.000 |
Why?
|
| Visual Acuity | 1 | 1982 | 2676 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 1980 | 2568 | 0.000 |
Why?
|
| Iron Isotopes | 1 | 1965 | 19 | 0.000 |
Why?
|